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ABSTRACT
NEUROPSYCHOLOGICAL SEQUELA OF MILD TRAUMATIC BRAIN INJURY:
A CONTEMPORARY META-ANALYTIC REVIEW

David E. Marra, MS
Marquette University, 2019

Mild traumatic brain injuries (MTBIs) result in a constellation of non-specific
physical, cognitive, and psychological symptoms. There is significant variability in
neurocognitive recovery after MTBI, ranging from a few days to a few months, and
others who fail to make complete recovery. A broad literature has attempted to elucidate
what individual differences explain this variability. The present study sought to build
upon previous meta-analyses, which systematically aggregated and examine relevant
literature, by including a more heterogenous population and utilizing contemporary metaanalytic techniques. Three online databases (PsychINFO, PubMed, MedLine) were
searched for pertinent studies. Separate random-effects Analogue-to-ANOVA were
utilized to examine the overall neurocognitive effects of MTBI across time points,
stratified by age, psychological comorbidity, populations of interest (athletes, general
medical referrals, Veterans, litigants), and whether performance validity tests (PVT) were
utilized. Subsequent analyses utilized meta-regressive techniques to simultaneously
examine the variables of interest. After article review, 109 studies were retained for
analysis (NMTBI = 5919, NControl = 8318). Analogue-to-ANOVA analyses revealed a
medium-large overall neurocognitive effect size in the first 24 hours post-injury (d = .64)
that decreased to a small effect size over the first 90 days (d = .24). Driven by a higher
number of Veteran and litigant samples, the effect size increased in the post-acute period
(> 90 days; d = .39). Veteran samples were observed to have significantly larger effect
sizes than other populations considered. Meta-regressive analyses found that, across
heterogenous populations, time since injury (TSI) was predictive of overall cognitive
function only prior to 90 days post-injury, but not in the post-acute period. Psychological
functioning was the most important predictor of cognitive functioning after MTBI (β =
.47), over and above TSI, population, demographic variables, injury parameters, age, or
PVT. This study is consistent with the growing research suggesting that psychological
functioning largely explains MTBI recovery and suggests that assessment of emotional
well-being and psychological functioning should be part of routine clinical care for the
management of MTBI.

i
ACKNOWLEDGEMENTS

David E. Marra, MS
I am incredibly indebted to so many wonderful people who have helped me, one
way or the other, through this incredible endeavor. First, to God, through Him all of this
was possible.
I am incredibly grateful and forever indebted to Dr. Hoelzle who adopted me into
his research family. Thank you so much for believing in me and creating an environment
where I could grow into the researcher and clinician that I am today. Thank you to my
incredible committee members, Drs. McCrea, Magnus, and Grych. I appreciate you all
suffering through a 100+ page document and providing meaningful recommendations and
suggestions to improve this project.
To my parents: thank you for all the love in support over the years. Thank you for
giving me an incredibly high target for success, humility, selfless, and gratitude that I
continually strive towards, and one day hope to achieve. To my incredible wife, Cynthia,
who has been there since day one: thank you for continually supporting me and
challenging me. I could not have done this without you! A special thank you to all my
siblings: Andrew, Joanna, Peters, Stephen, Mark, John Michael, and Annalise.
I wanted to thank my incredible lab mates, Beth, Katie, and Morgan. Thank you
for being such a beacon of positivity, Beth. And a huge thank you to Katie and Morgan
for the innumerable hours spent reviewing and coding articles and suffering through my
YouTube tutorial videos. I also am incredibly grateful for the incredible research
assistants, especially Ellie and Lexi, who were instrumental in gathering and aggregating
the data used in these analyses. Research assistants are the unsung heroes from which
nearly all research is carried out.
Thank you to innumerable individuals who assisted with various aspects of this
project. Thank you to the Marquette Librarians for helping with my article search criteria
and citation management. Thank you to Dr. Jackson from MCW for his methodological
consultation. And a special thank you to all the bartenders who did not judge me for
working on my dissertation at the bar.
Finally, I wanted to thank the NIH and the TL1 Fellowship for funding this
project. I am forever grateful I did not have to teach undergraduate statistics for another
year.
This project was supported by the National Center for Advancing Translational Sciences,
National Institutes of Health, through Grant Numbers UL1TR001436 and TL1TR001437.
Its contents are solely the responsibility of the authors and do not necessarily represent
the official views of the NIH.

ii
TABLE OF CONTENTS
ACKNOWLEDGMENTS…………………………………………………………………i
CHAPTERS
I.

INTRODUCTION…………………………………………………………….1
Defining MTBI……………………………………………………………1
Prevalence and Significance………………………………………………5
Epidemiology and Mechanism of Injury………………………………….7
Symptom Recovery……………………………………………………….8
Possible Modifiers of Cognitive Recovery after MTBI………….……….9
MTBI Meta-Analytic Reviews…………………………………………..20
Meta-Regression…………………………………………………………26
Present Study…………………………………………………………….28

II.

PRIMARY AIMS……………………………………………………………30
Aim 1……………………………………………………………….……30
Aim 2……………………………………………………………….……30

III.

METHODS…………………………………………………………………..32
Institutional Review and Best Practice Guidelines………………………32
Literature Search and Inclusion Criteria…………………………………32
Data Extraction and Evaluation of Inter-rater Reliability………………..34
Variables of Interest……………………………………………………...34
Effect Size Calculations………………………………………………….40
Outlier Analysis………………………………………………………….44
Data Analysis…………………………………………………………….45

iii

Power Analysis………………………………………………………..…49
IV.

RESULTS……………………………………………………….………..….51
Outlier Analysis and Publication Bias…………………………………...53
Aim 1: Pair-Wise Meta-Analytic Findings………………………………59
Aim 2: Meta-Regression Analyses………………………………………80
Supplemental Analyses…………………………………………………..86

V.

DISCUSSION………………………………………………………………..94
Aim 1…………………………………………………………………….95
Aim 2…………………………………………………………………….99
Methodological Considerations………………………….……………..103
Clinical Implications……………………………………………………108
Summary………………………………………………………………..109

REFERENCES…………………………………………………………………………111
APPENDIX A………………………………………………………………………….125
APPENDIX B………………………………………………………………………….126
APPENDIX C………………………………………………………………………….129

1
Neuropsychological Sequela of Mild Traumatic Brain Injury:
A Contemporary Meta-Analytic Review

A traumatic brain injury (TBI), generally, occurs when brain functioning is
disrupted or brain pathology arises due to an external force (Menon, Schwab, Wright, &
Maas, 2010). Researchers and clinicians typically classify TBI by severity (e.g., mild,
moderate, severe). Seventy to ninety percent of all medically treated TBIs are mild in
nature (Cassidy et al., 2004). Mild traumatic brain injury (MTBI), or concussion, is
extremely common, affecting as many as 42 million people annually and 12 percent of all
individuals during their lifetime (Cassidy et al., 2004).
MTBI may result in a constellation of non-specific physical, cognitive, and
psychological symptoms (McCrea, 2008). For most individuals, these symptoms resolve
in fewer than three months (Carroll et al., 2004). However, for reasons not completely
understood, a small, yet significant number of individuals continue to experience
distressing symptoms years after an injury. Furthermore, the relationship between these
chronic, self-reported symptoms and neuropsychological outcomes are poorly
understood. The cognitive sequela that arise post-MTBI appear to differ across time for
different patient populations. Thus, it is critically important to consider how biological,
psychological, and/or social factors impact recovery.
Defining MTBI
Until recently, there was no universally accepted definition of MTBI. The lack of
a sound operational definition for diagnosis has resulted in considerable discrepancies in
the MTBI literature (Cassidy et al., 2004). In addition, standard imaging techniques, such
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as MRIs and CT scans, do not detect “uncomplicated” MTBIs (i.e., a MTBI that does not
result in cranial fracture or intracranial bleed) and therefore have low diagnostic utility.
More sophisticated imaging techniques, such as Diffusion Tensor Imaging (DTI) can
detect group-level differences between concussed and non-concussed individuals (e.g.,
Ivanov et al., 2017); however, these imaging techniques are not yet sensitive enough for
routine clinical application (Asken, DeKosky, Clugston, Jaffee, & Bauer, 2017 Jaffee, &
Bauer, 2017). At present, the same holds true for other biomarkers, such as cerebral
spinal fluid and bloodwork (Lewis et al., 2017; c.f., Nitta et al., 2019).
The diagnosis of MTBI is made on the basis that a transient disruption of
cognitive functioning that occurred due to a direct or indirect impact to the head. The
American Congress of Rehabilitation Medicine (ACRM) and the World Health
Organization (WHO) Task Force (Carroll et al., 2004) provide two well-accepted MTBI
definitions. Both the ACRM and WHO Task Force define MTBI as an acute disruption of
brain functioning due to trauma that manifests as one or more of the following (1) loss of
consciousness (LOC) less than 30 minutes, (2) altered mental state (e.g., dazed,
disoriented, or confused), (3) pre- or post-traumatic amnesia less than 24 hours, and (4) a
Glasgow Coma Scale score between 13-15 after 30 minutes (see Table 1 for complete
diagnostic criteria). Uniquely, relative to earlier diagnostic criteria, these classification
systems do not require the presence of LOC. The main difference between the two
classification systems, the ACRM allows for any alteration of mental state (e.g., feeling
dazed) at the time of the accident, whereas the WHO Task Force definition specifies
“confusion and disorientation.” While both definitions exclude patients with more severe
injuries, critics emphasize that TBI severity should be conceptualized as a continuum
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(Roozenbeek, Maas, & Menon, 2013). Nonetheless, these definitions operationalize
MTBI, which certainly facilitates more reliable clinical judgement and improves
research.
Table 1.
Definitions of Mild Traumatic Brain Injury and Concussion from Different Agencies
ACRM (1993)
A patient with mild traumatic brain injury is a person who has had
a traumatically induced physiological disruption of brain function,
as manifested by at least one of the following:
1. Any period of loss of consciousness;
2. Any loss of memory for events immediately before or after
the accident;
3. Any alteration in mental state at the time of the accident
(e.g., feeling dazed, disoriented or confused); and
4. Focal deficits that may or may not be transient; but where
the severity of the injury does not exceed the following:
• Loss of consciousness for approximately thirty minutes
or less;
• After 30 minutes an initial GCS of 13-15
• Past-traumatic amnesia not greater than 24 hours

WHO Task
Force (2004)

MTBI is an acute brain injury resulting from mechanical energy to
the head from external physical forces. Operational criteria for
clinical identification include: (i) 1 or more of the following:
confusion or disorientation, loss of consciousness for 30 minutes or
less, post-traumatic amnesia for less than 24 hours, and/or other
transient neurological abnormalities such as focal signs, seizure,
and intracranial lesion not requiring surgery; (ii) GCS score of 1315 after 30 minutes post-injury or later upon presentation for
healthcare. These manifestations of MTBI must not be due to
drugs, alcohol, medications, caused by other injuries or treatment
for other injuries (e.g., systemic injuries, facial injuries or
intubation), caused by other problems (e.g., physiological trauma,
language barrier or coexisting medical conditions) or caused by
penetrating craniocerebral injury

International
Conference of
Concussion in
Sport (2013)

Concussion is a brain injury and is defined as a complex
pathophysiological process affecting the brain, induced by
biomechanical forces. Several common features that incorporate
clinical, pathologic, and biomechanical injury constructs that may
be utilized in defining the nature of a concussive head injury
include:

4

International
Conference of
Concussion in
Sport (2013)
Continued

1. Concussion may be caused by a direct blow to the head,
face, neck, or elsewhere on the body with an “impulsive”
force transmitted to the head.
2. Concussion typically results in the rapid onset of shortlived impairment of neurological function that resolves
spontaneously. However, in some cases, symptoms and
signs may evolve over a number of minutes to hours
3. Concussion may result in neuropathologic changes, but the
acute clinical symptoms largely reflect a functional
disturbance rather than a structural injury, and as such, no
abnormality is seen on standard structural neuroimaging
studies.
4. Concussion results in a graded set of clinical symptoms that
may or may not involve loss of consciousness. Resolution
of the clinical and cognitive symptoms typically follows a
sequential course. However, it is important to note that in
some cases, symptoms may be prolonged.

Note. ACRM = American College of Rehabilitation Medicine; WHO = World Health
Organization; GCS = Glascow Coma Scale

Although the terms MTBI and concussion are often used interchangeably, some
argue that sports-related concussion (SRC) is not synonymous with MTBI, but rather
reflects a subset of mild head traumas (McCrory et al., 2013). In a Consensus Paper from
the 4th International Conference on Concussion of Sport, concussion was defined as, “a
complex pathophysiological process affecting the brain, induced by biomechanical
forces” (McCory et al., 2013, pp. 555). The paper also clarifies that a concussion may be
the result of a blow or forces transmitted to head that results in acute neurologic
dysfunction (LOC may or may not occur). In principle, there is significant overlap
between how concussion and MTBI are defined (Table 1); they are considered
synonymous and analyzed together in the present study.
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Prevalence and Significance
The failure to develop an agreed upon diagnostic criterion for MTBI until early
2000 made determining the “true” prevalence rate challenging. The Center for Disease
Control examined Emergency Department records across the United States from 20022006 and estimated that 1.7 million individuals are medically treated or fatally injured
due to TBI each year (Faul, Xu, Marlena, & Coronado, 2010). In a later report to
Congress (Frieden, Houry, & Baldwin, 2015), it was acknowledged that the previous
estimate of 1.7 million individuals was likely low as it did not account for individuals
who were treated in non-hospital settings, individuals who did not receive treatment, or
Veterans who were treated at Veteran Affairs (VA) medical centers. One meta-analysis
attempted to quantify MTBI prevalence rates by examining the prevalence rate from all
published studies (Cassidy et al., 2004). The authors found pervasive heterogeneity in
methodology across studies. For example, MTBI was variably defined, if at all, by
authors. Due to the extent of the methodological variability between studies, the authors
expressed hesitation in providing a single incidence rate. Nonetheless, based on the
available data, Cassidy and colleagues estimated the incidence rate to be between 100 to
300 per 100,000 adults. Much like the CDC, the authors acknowledged that this estimate
is likely an underestimate as a majority of MTBIs are not medically treated. It was
estimated that the likely incidence rate approaches 600 per 100,000 adults.
Athletes are also susceptible to TBI and the CDC estimated that 300,000 athletes
in the United States sustain a concussion annually (Thunnan, Branche, & Sniezek, 1998),
or 1.64 per 100 athlete-seasons across all sports (Powell & Barber-Foss, 1999). However,
this may be a gross underestimate as almost half of all SRC go unreported (McCrea,
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Hammeke, Olsen, Leo, & Guskiewicz, 2004). This is especially problematic as resuming
physical activities, especially participating in contact sports, prior to symptom resolution,
may increase risk of sustaining another brain injury (Guskiewicz et al., 2003).
Military personnel are also particularly vulnerable to TBIs. In fact, MTBI are so
pervasive for active duty members it is considered the hallmark injury of recent military
conflicts. As the mortality of soldiers have decreased over time, the prevalence of TBIs in
this population has increased. From October 1, 2001, the start of Operation Enduring
Freedom (OEF), to the end of 2011, 235,046 service members (4.2%) were diagnosed
with a TBI (The CDC, NIH, DoD, and VA Leadership Panel, 2013). In 2011, alone,
33,149 military personnel were diagnosed with a TBI. During the same 10-year period,
7.7% of all services sought at VAs were from OEF and Operation Iraqi Freedom (OIF)
personnel for TBI-related conditions. Similar to other MTBI estimates, these numbers
may underestimate the true number of TBIs as many MTBIs are likely not recognized or
reported in combat theater.
Traumatic brain injury clearly represents a major public health issue. The
economic cost of TBI is disproportionately larger than other injuries (Ma, Chan, &
Carruthers, 2014; Max, MacKenzie, & Rice, 1991), with the estimated cost of treatment
approaching $13.1 billion per year and an additional $64 billion are estimated to be lost
due to indirect costs (e.g., inability to work, disability) (Rutland-Brown, Langlois,
Thomas, & Xi, 2006). Furthermore, 3.32 million individuals (1.1% of total population)
are living with long-term disability due to TBI (Zaloshnja, Miller, Langlois, & Selassie,
2008 & Selassie, 2008). Even though more than 70% of TBIs are considered “mild” in
severity (CDC, 2010; Cassidy et al., 2004), in some individuals, these injuries can still
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result in permanent or long-term problems that negatively impact one’s ability to function
(e.g., see Alves, Macciocchi, & Barth, 1993; Englander, Hall, Stimpson, & Chaffin,
1992).
Epidemiology and Mechanism of injury
Previously, motor vehicle accidents (MVAs) were the primary mechanism for
TBIs (Cassidy et al., 2004). However, as driving policies and vehicles are becoming
safer, the overall number of MVAs are decreasing, thus leading to a reduction in MVArelated TBIs (Roozenbeek et al., 2013). Simultaneously, as the population grows older
and life expectancy increases, the number of TBIs related to falls are increasing. In fact,
an estimated 35.2% of all emergency department visits, hospitalizations, and deaths are
fall-related (vs. 17.3% for MVAs; CDC, 2010). Older adults over the age of 75 now have
the second highest incidence rate of TBIs, second only to younger adults, aged 15-19
(Faul et al., 2010). Altogether, the median age of TBIs is now shifting to an older age
(Roozenbeek et al., 2013).
After a physical trauma, neurologic dysfunction may arise from either contact
(blunt trauma) or inertial forces (acceleration/deceleration). The primary biophysical
mechanisms of an MTBI arises from inertial forces (acceleration/deceleration) that is
transferred to the brain (Meaney & Smith, 2011). Early efforts to understand the
relationship between these forces and brain dysfunction focused on linear acceleration
and deceleration (Meaney & Smith, 2011). Animal models showed a positive correlation
with the initial increase of pressure in the brain and acceleration forces, which predicted
neurologic dysfunction. However, understanding of the mechanisms of a TBI has shifted
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to understand that the rotational forces exerted on the brain may be the predominant
mechanism of injury (Gennarelli et al., 1982; Unterharnscheidt & Higgins, 1969). During
rotational acceleration/deceleration, neuronal axons can tear or shear away from the cell
body (Smith, Meaney, & Shull, 2003). The axonal tearing and shearing results in diffuse
axonal injury (DAI), and DAI severity is associated with poorer neurological outcomes.
In fact, if the head and neck are immobilized such that rotational forces cannot be
applied, it is more difficult to produce unconsciousness from a physical trauma (Meaney
& Smith, 2011).
Symptom Recovery
Unlike moderate and severe TBI, the non-specific constellation of cognitive,
physical, and emotional symptoms the arise post-MTBI are not reliably predicted by
injury parameters (e.g., loss of consciousness, post-traumatic amnesia) (McCrea, 2008).
Clinicians and researchers track recovery post-MTBI through self-report of postconcussive symptoms (PCS). Common self-reported PCS include, but are not limited to,
headaches, dizziness, cognitive slowing, difficulty concentrating, light and noise
sensitivity, fatigue, drowsiness, and memory difficulties. Important to recognize, many
MTBI symptoms are non-specific and may be difficult to distinguish from common
experiences and/or symptoms associated with other mental health conditions (e.g., PostTraumatic Stress Disorder) (American Psychiatric Association, 2013). For instance, as
many as 75.7% of healthy volunteers reported experiencing PCS in the past two-weeks
(e.g., headaches) despite the absence of a head injury (Iverson & Lange, 2003).
Furthermore, there is evidence that certain populations, such as athletes, tend to
underreport symptomology (McCrea, 2008), whereas other populations, such as

9
individuals involved in litigation, tend to over report symptomology (Feinstein,
Ouchterlony, Somerville, & Jardine, 2001). Thus, there is need for more objective
measures with high sensitivity and specificity to MTBI symptoms, which is crucial for
accurate diagnosis and to monitor symptom recovery of MTBI.
Given their relative objectivity and sensitivity to MTBI, neuropsychological
measures are regularly utilized during a clinical evaluation to diagnose and monitor
symptom recovery post-MTBI (McCrea, 2008). For example, in longitudinal study
following 1,631 NCAA athletes, McCrea and colleagues found that a group of concussed
athletes were reportedly asymptomatic based on self-report after two days, yet, continued
to show impairment on balance and neuropsychological testing seven days post-injury
(McCrea et al., 2005). Thus, the authors advocated that neuropsychological assessment is
vital in detecting the subtle, residual effects of sustaining an MTBI, even in the absence
of reported symptoms. In fact, a meta-analysis found that, in non-litigant samples,
neurocognitive measures were sensitive to detecting the acute cognitive effects of a
MTBI in nearly all cognitive domains (Belanger, Curtiss, Demery, Lebowitz, &
Vanderploeg, 2005).
Possible Modifiers of Cognitive Recovery after MTBI
There is considerable variability regarding the cognitive effects of sustaining an
MTBI. For example, some researchers have documented a small overall effect size (d =
.11) at 1-month post-MTBI (Ponsford, Willmott, et al., 2000), whereas others have
reported a moderate-large effect size (d = .64) for a similarly aged sample over the same
time period (Voller et al., 1999). Likewise, some studies, particularly those investigating
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athletes, show a non-significant effect size after approximately seven days (McCrea et al.,
2003), whereas other studies document that that the neurocognitive effects do not resolve
until three or more months (e.g., Kwok, Lee, Leung, & Poon, 2008). The discrepant
findings between studies (i.e., between-study heterogeneity) may be due to one of any
number of factors that appear to contribute to the individual differences seen in cognitive
recovery. A review of primary potential effect modifiers is outlined below.
Population. The course of neuropsychological recovery post-MTBI drastically
differs depending on the “population” (i.e., athlete, Veteran, general-medical referral,
litigant) investigated. Numerous studies have demonstrated that cognitive effects of
MTBI in athletes are largely resolved in about one week (Belanger & Vanderploeg, 2005;
Macciocchi, Barth, Alves, Rimel, & Jane, 1996; McCrea et al., 2003; McCrea, Kelly,
Randolph, Cisler, & Berger, 2002). On the other hand, individuals who are prospectively
recruited from emergency departments and medical clinics (i.e., general medical referrals,
GMR) may take one to three months before neuropsychological symptoms resolve. For
instance, many studies have reported significant effect size differences at least one month
after MTBI (Dikmen, Machamer, & Temkin, 2017; McAllister et al., 2001; c.f., Gentilini
et al., 1985). Similarly, some studies have shown significant effect sizes three months
after the initial injury (Belanger, Curtiss, et al., 2005; Gentilini, Nichelli, & Schoenhuber,
1989; c.f., Ponsford, Willmont, et al., 2000). There are many likely reasons for the
discrepancy in cognitive recovery between athletes and the general population that
sustains an MTBI. First, athletes tend to be younger and healthier (i.e., high school and
college) and have high motivation to return to play (McCrea, 2008). Furthermore, the
mechanism of injury may differ for athletes and the general population. For instance, the
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most common reason for an MTBI to be medically treated is due to a fall or MVA (Faul
et al., 2010). The acceleration/deceleration forces associated with these events may be
inherently different from SRC.
As previously noted, MTBI is a significant concern in military populations.
Despite MTBI being the “hallmark” injury of OEF/OIF, there are unique challenges
associated with studying MTBI in this population. Traumatic brain injury is often
overlooked in favor of treating and triaging more obvious physical injuries such as
wounds or traumatic amputations (Belanger, Scott, Scholten, Curtiss, & Vanderploeg,
2005) and details related to injury parameters or post-injury recovery are infrequently
documented (Belanger, Uomoto, & Vanderploeg, 2009). Alteration of consciousness may
go unnoticed in theater, or may be confused with the emotional reaction or adrenaline
rush likely to accompany traumatic military experiences (Belanger et al., 2009). Finally,
from a pragmatic standpoint, neuropsychological evaluations are unlikely to be
conducted in combat theater (Dolan et al., 2012). Nevertheless, one study investigating
the acute effects of an MTBI found that Veterans with MTBI who were assessed in the
first 24 hours performed significantly worse (large effect size) compared to a normative
sample of non-concussed Veterans on a brief cognitive screener (McCrea et al., 2014). It
is unclear when residual cognitive symptoms resolved because follow-up testing was not
conducted in the study. Thus, it is unclear if these acute cognitive symptoms resolve in a
few days, like athletes, or over the course of several months, similar to non-athletic
civilians.
Most of the research investigating how active service members and Veterans
function post-injury have been conducted months and years after TBI. However,
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ascertaining the neurocognitive effects of MTBI in this population is difficult because of
several factors. Some research suggests, there is little-to-no long-term cognitive effects in
Veterans post-deployment who suffer an MTBI when other comorbidities are absent
(Combs et al., 2015; Nelson et al., 2012; Vasterling et al., 2012; Verfaellie, Lafleche,
Spiro, & Bousquet, 2014). However, there is compelling evidence to suggest a potential
negative neurocognitive effect of comorbid mental health conditions and MTBI. For
example, Veterans with co-morbid mental-health disorders performed significantly worse
on neurocognitive assessments compared to Veteran controls (Nelson et al., 2012) or
Veterans who sustained an MTBI with no mental health comorbidities (Combs et al.,
2015; Verfaellie et al., 2014). Salient secondary gain issues in VA settings may also
complicate cognitive recovery in Veterans due to the limited nature of VA healthcare
post-deployment. Absent of a service-connected disability, Veterans in the US are
granted only five years of VA healthcare post-deployment ("Returning Service Members
(OEF/OIF/OND) - Health Benefits," 2014). Thus, there are clear incentives for Veterans
to report symptomology of MTBI as early as possible (Rona et al., 2012), and there is an
incentive to suppress performances when completing neurocognitive measures.
Illustrating the latter, as many as 58% of a sample referred for a TBI evaluation in the VA
system failed a performance validity test (PVT), which is a type of test designed to assess
for sub-optimal test engagement or purposeful performance suppression (ArmisteadJehle, 2010).
Importantly, insufficient effort and issues with secondary gain are not limited to
Veterans who experience an MTBI but are also a confounding issue with civilians who
are involved in the litigation process related to their TBI (e.g., individuals involved in a
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motor vehicle accident and claiming disability). Members of the “litigant” population
tend to experience greater subjective symptoms (Feinstein et al., 2001) and perform
worse on measures of neurocognitive functioning. In fact, a meta-analysis found that the
cognitive effects of MTBI for individuals in this group worsen over time, rather than
resolve (Belanger, Curtiss, et al., 2005). In a large sample of individuals involved in
litigation for MTBI, 40% failed an established PVT (Flaro, Green, & Robertson, 2007
2007). In fact, the failure rate of the litigation group with MTBI was 23 times higher than
a group with high motivation to perform well and twice as large as the rate observed in
samples with more severe TBI. There is clear evidence that poor effort during the
forensic evaluation accounts for much of the variance in cognitive testing (Green,
Rohling, Lees-Haley, & Allen, 2001). It seems that individuals with potential secondary
gain issues may follow a different trajectory of cognitive recovery due to factors not
related to the injury, such as insufficient effort and symptom exaggeration. Thus, the true
nature of their cognitive recovery is unknown.
Age. A significant portion of the MTBI literature investigates high school and
college athletes. Fewer empirical studies focus on children and older adults. This
discrepancy is notable given that children aged 0-4 years have the highest rate of ED
visits due to TBI and adults aged 75 and older have the highest rate of hospitalizations
and death due to TBI (Faul et al., 2010). This section will summarize research findings
specific to these age groups to make clear that age has the potential to impact recovery.
Studies on the acute cognitive effects of MTBI in pediatric samples are limited, in
part because there are unique challenges associated with diagnosing MTBI in young
children. For example, because language skills are not fully developed, it is difficult to

14
assess symptoms post-injury (Anderson, Catroppa, Morse, Haritou, & Rosenfeld, 2001).
Nevertheless, one prospective study found that children aged 6-18 years had marginally
lower (but not significantly lower) scores on a brief cognitive screener compared to
controls with orthopedic injuries when evaluated acutely in an ED (Grubenhoff,
Kirkwood, Gao, Deakyne, & Wathen, 2010). In another study, children who presented to
an ED performed below children with orthopedic injuries on measures of psychomotor
speed and reaction time (Brooks, Khan, Daya, Mikrogianakis, & Barlow, 2014). The
patient groups did not perform differently on measures of memory, attention, and
executive functioning.
Consistent with the adult literature, there is variability and conflicting findings
regarding long-term outcomes for children who sustain MTBI. While some researchers
report no long-term sequela associated with pediatric MTBI (e.g., Ponsford et al., 1999),
others express concerns regarding the possibility of long-term sequala (e.g., Anderson et
al., 2001). In fact, a systematic review of 40 articles published between 1970 to 1995
regarding MTBI in children and adolescents categorized 13 articles suggesting poor
outcomes, 18 with null findings, and 9 that were uncertain regarding cognitive, academic,
and psychosocial outcomes (Satz et al., 1997). Importantly, after reviewing only
methodologically strong studies, the authors posited that there are few adverse or longterm effects.
Consistent with the adult literature, children and adolescents’ pre-existing
conditions and psychological comorbidities likely impact MTBI recovery. A longitudinal
study conducted by researchers at UCLA found that, compared to controls with
orthopedic injuries, the only predictors of cognitive impairment 1- and 12-months post-
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injury were parental education level, pre-injury behavioral issues, academic achievement,
and pre-injury learning disorders (Babikian, McArthur, & Asarnow, 2013). Additionally,
research has documented that children who continue to experience behavioral issues for
extended periods of time post-MTBI are more likely to have had a previous head injury,
learning difficulties, pre-injury emotional and behavioral problems, psychiatric problems,
and/or additional neurological issues (Ponsford et al., 1999). In an additional study,
children who sustained an MTBI and had pre-morbid attentional difficulties had poorer
neuropsychological outcomes relative to children who sustained an orthopedic injury
(Studer et al., 2014). Taken together, while it appears that children and adolescents
demonstrate acute cognitive impairments post-MTBI that largely resolve during the
course of a month, pre-existing factors may delay full recovery.
Consistent with child and adolescent literature, the research regarding cognitive
outcomes for older adults who sustain an MTBI is mixed. There are a number of studies
that have identified adverse cognitive outcomes for older adults who sustain MTBI (e.g.,
de la Plata et al., 2008; Goleburn & Golden, 2001; Rapoport & Feinstein, 2000).
Conversely, there are numerous studies suggesting that there are no adverse long-term
outcomes for older adults who sustain an MTBI (e.g., Feinstein et al., 2001; Mosenthal et
al., 2004; Rapoport et al., 2008). At closer inspection, the adverse cognitive effects may
be a result of secondary factors, such as pain, or psychological distress. For example,
there is evidence that older adults who sustain an MTBI perform worse than same-aged
controls on measures of neuropsychological functioning than non-injured controls, but
not worse than individuals who sustained orthopedic injuries (Kinsella, Olver, Ong,
Gruen, & Hammersley, 2014) Thus, the injury characteristics (e.g., pain, medication,
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altered sleep cycle) may account for the worse cognitive functioning, rather than the
MTBI, itself. In addition to injury characteristics, older adults who sustain an MTBI were
found to have higher rates of depression and anxiety symptoms relative to healthy
controls (Goldstein, Levin, Goldman, Clark, & Altonen, 2001), which places older adults
at a higher risk for adverse cognitive outcomes (Dotson, Resnick, & Zonderman, 2008b) .
Psychological Comorbidities, Pre-Injury Disposition, and Post-Concussive
Symptomatology. Even in the absence of a head injury, psychological distress and
mental health disorders are associated with worse neurocognitive functioning (e.g.,
Dotson et al., 2008b; Gualtieri, Johnson, & Benedict, 2006; Snyder, 2013). Thus, it is
unsurprising that the presence of a comorbid psychological disorder may prolong or
complicate neuropsychological recovery from an MTBI (Combs et al., 2015; Nelson et
al., 2012; Verfaellie et al., 2014). However, many additional factors, such as personality
features and coping mechanisms, even in the absence of a comorbid mental health
diagnosis, can extend or be the direct cause of continued symptomatology in patients who
sustain an MTBI. For example, pre-injury somatization, anxiety sensitivity (i.e., anxietyrelated somatic symptoms), alexithymia (i.e., difficulty understanding and describing
emotions), and depressive personality traits, have all been found to predict duration of
post-concussive symptomology (Nelson, Tarima, et al., 2016; Wood, O'Hagan, Williams,
McCabe, & Chadwick, 2014; Yuen, Tsai, Lin, Yang, & Huang, 2016) Interestingly, even
in healthy, non-concussed research participants, self-reported symptoms consistent with
PCS align with maladaptive personality constructs. Specifically, students who reported
higher “PCS” reported more negative, depressive, anxious, dependent, sadistic, somatic,
and borderline traits (Garden, Sullivan, & Lange, 2010).
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The relationship between PCS symptomatology and neurocognitive functioning is
less clear, however, as some studies found an association between neurocognitive
dysfunction and prolonged PCS (Collie, Makdissi, Maruff, Bennell, & McCrory, 2006;
Iverson, Gaetz, Lovell, & Collins, 2004; Sterr, Herron, Hayward, & Montaldi, 2006), and
others have not (Chan, 2001). Stulemeijer and colleagues (2007) examined the direct link
between pre-injury factors, PCS, and neuropsychological functioning longitudinally by
recruiting patients from an ED and conducting evaluations 6 months post-MTBI
(Stulemeijer, Vos, Bleijenberg, & van der Werf, 2007). Participants were dichotomized
into groups based on cognitive complaints. Interestingly, while the high-cognitive
complaint group did have worse pre-injury and post-injury psychological and emotional
well-being, there were no differences in neuropsychological performance between
groups. Thus, a clear connection between pre- and post-injury psychological functioning,
reported PCS, and neuropsychological performance was not established. In contrast,
another study found that worse cognitive functioning was predicted by greater cognitive
complaints, PCS, and affective factors (depression, anxiety, and neuroticism) in
individuals with MTBI (Clarke, Genat, & Anderson, 2012). The discrepant findings may
be a result of the latter authors’ decision to exclude a significant portion of their sample
(27%) due to insufficient effort. Thus, the association between poor neurocognitive
functioning and PCS and affective symptoms in Clark and colleagues’ (2012) study may
be an artifact of not considering whether the examinees were adequately engaged with
testing. Thus, the link between PCS and neurocognitive functioning remains somewhat
unclear.
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Secondary Gain and Insufficient Effort. Secondary gain issues, insufficient
effort, or exaggerated symptom reporting may confound interpretation of neurocognitive
performance during standard clinical evaluations, medicolegal forensic assessments, and
research protocols. As previously noted, Veterans may perceive an incentive to
exaggerate symptom complaints or suppress cognitive performance to increase the
probability of receiving service-connected disability (Hoge, Goldberg, & Castro, 2009;
Rona et al., 2012). Similarly, the dramatic costs associated with healthcare and
rehabilitation services may increase the likelihood that an examinee may put forth
insufficient effort during assessments (Bigler, 2008). Indeed, this is documented, with as
many as 58% of Veterans putting forth sub-optimal effort (Armistead-Jehle, 2010) and
much of the variability (as much as 50%) in cognitive performance being explained by
insufficient effort (e.g., Armistead-Jehle, 2010; Green et al., 2001; Nelson et al., 2010).
As expected, individuals who fail PVTs perform poorer on cognitive testing than
individuals who pass PVT, even after sustaining an MTBI (e.g., Jak et al., 2015;
Stulemeijer et al., 2007).
It is important to recognize that insufficient effort and PVT failure during
neuropsychological evaluations are not limited to individuals with potential for secondary
gain. PVT failure also frequently occurs in individuals experiencing emotional distress.
For example, in a sample of patients with MTBI who were recruited from an ED and
evaluated six months post-MTBI, 27% of the sample failed a PVT (Stulemeijer et al.,
2007). Those who failed a PVT did worse on almost all neuropsychological measures.
Though, PVT failure was not associated with involvement in litigation, it was associated
with higher emotional distress, greater negative affectivity (i.e., tendency to experience
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distress), lower education, failing to return to work, and fatigue. Similarly, in a large
sample of OIF/OEF Veterans who sought treatment for an MTBI, 30% of the sample
failed at least one PVT (Jak et al., 2015). In addition, 74% and 85% of the individuals in
the group that failed at least one PVT carried a clinical diagnosis of depression and/or
PTSD, respectively. The prevalence of these disorders occurred at a significantly higher
incidence rate relative to the group that passed all PVTs. Consistent with these general
findings, individuals with a history of a mental health issues are four times more likely to
fail one or more PVTs during an MTBI evaluation (Donders & Boonstra, 2007).
In summary, issues unrelated to MTBI injury parameters can lead to poor effort
during neuropsychological assessment and suppressed cognitive performance. Thus, it is
crucial for clinicians to consider the possibility of insufficient effort when quantifying
neurocognitive symptoms associated with MTBI and subsequent recovery.
Summary of Effect Modifiers. There are a multitude of factors that can
potentially affect the neuropsychological recovery from an MTBI: population, age,
psychological comorbidities, performance invalidity, to name a few. Yet, almost none of
these issues are mutually exclusive. For instance, psychological comorbidities are not
only found in Veterans, but can also be found in civilians. Performance invalidity is not
limited to individuals involved in litigation. Athletes, who are typically motivated to
return to play, may have maladaptive coping mechanisms or depressive personality
characteristics that may increase the likelihood of prolonged cognitive recovery. None of
these individual differences occur in isolation, but rather are complexly interwoven into
multifaceted biopsychosocial mechanisms that can affect recovery (see Figure 1). Thus, it
is extremely challenging to conduct empirical studies evaluating the intersection of these
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individual differences. Rather, quantitative reviews of a multitude of studies may
elucidate the unique contributions these individual differences make to cognitive
recovery after sustaining an MTBI.
Figure 1.
Illustration of the Biopsychosocial Factors that May Affect Outcome After MTBI

Note: MVA = Motor Vehicle Accident; SRC = Sports-Related Concussion; LD =
Learning Disorder; ADHD = Attention Deficit/Hyperactivity Disorder; TBI = Traumatic
Brain Injury

MTBI Meta-Analytic Reviews
There is an emerging literature examining how individual differences might affect
cognitive recovery after an MTBI, though there are discrepancies in these findings. Thus,
there is a critical need for comprehensive quantitative analysis to integrate available
research to elucidate the neuropsychological effects of sustaining an MTBI across broad
populations. In brief, meta-analyses critically integrate and analyze the results of multiple
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studies. Data from multiple studies are aggregated, “averaging” effect sizes reported in
relevant studies. Relative to a single study, a meta-analytic review has increased power to
detect a “true” effect if one exists (Bartolucci & Hillegass, 2010; Cohn & Becker, 2003).
Furthermore, by pooling the results of multiple studies, meta-analyses often include a
more heterogeneous pool of participants than a single study, which increases the
generalizability of estimated effects (Bartolucci & Hillegass, 2010; Borenstein, Hedges,
Higgins, & Rothstein, 2009). Several meta-analyses have been conducted examining the
neuropsychological effects of sustaining an MTBI (See Table 2). While this body of
literature has dramatically improved our understanding of MTBI, several notable
methodological issues are present across studies and will be expanded upon below.
Binder, Rohling, and Larrabee (1997) conducted the first meta-analytic review to
investigate the neuropsychological impact of MTBI. The review included 11 studies that
examined mild head trauma (MHT; NMHT = 314; NControls = 308). All the studies were
conducted at least 3 months post-injury and a small and non-significant overall effect size
(i.e., estimated effect size of all cognitive constructs combined) was reported (Cohen’s d
(d) = .12; Hedge’s g (g)= .07), suggesting no significant, negative cognitive effects of
MTBI after three months. The researchers also examined whether MTBI might affect
specific neuropsychological constructs and concluded that attention is mildly impacted (d
= .20; g = .17) after 3 months or more. While this meta-analytic review is seminal in
nature, there are some notable limitations that should be recognized. First, the number of
included studies was relatively small (k = 11) and a single study contributed nearly half
(51%) of the patients with MHT. In addition, considerable between-study statistical
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Table 2.
Summary of All Known Meta-Analyses Examining Neuropsychological Effects of MTBI
First
Population Total
Author
Year of Interest
K
Sub-group Comparison
k
d
Binder
1997 Mixed
11
11 0.12*
Frenchama

2005

Mixed

17

Acute (< 3 months)
Post-Acute (> 3 months)
Total

12 0.33*
5 0.28
17 0.32*

Belanger

2005a

Clinical/
medical
referrals

39

Litigation-based sample < 90 days

2

0.52*

Litigation-based sample ≥ 90 days
Clinic-based sample < 90 days

6
-

0.78*
-

Clinic-based sample ≥ 90 days
Unselected sample < 90 days
Unselected sample ≥ 90 days

11 0.74*
23 0.63*
8 0.04

Within 24 hours: Self as control
Within 24 hours: Non-concussed
control group
1-7 days: Self as control
1-7 days: Non-concussed control
group
7+ days: Self as control
7+ days: Non-concussed control
group

5

Belanger

2005b Athletes

21

0.44*

10 0.97*
11 -0.08
11 0.43*
5 -0.65
6

0.22*
-0.09

Pertab

2009

Mixed

18

> 3 months

18

Rohling

2011

Re-analysis
of:
Binder
(1997)
Frenchman
(2005)
Pertab
(2009)

48

< 7 days

16 0.39*

8-30 days
31-92 days

12 0.32*
4 0.14

> 93 days
All time points

16 0.17
48 0.28*

< 6 months - FSIQ
> 6 months - FSIQ
< 6 months - PIQ
> 6 months - PIQ

3
2
4
3

Konigs

2012

Mixed

21

0.08
-0.07
0.12
-0.05
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Green

Dougan

Dougan

2013

2014a

2014b

Mixed

Athletes

Athletes

13

91

< 6 months - VIQ
> 6 months VIQ

3
2

-0.26
-0.36

Studies with AAN Methodology
Rated I or II
Studies with AAN Methodology
Rated III or IV

7

.52*

5

.38*

Aggregate across all comparison
groups
Compared to baseline and control
group
Independent Control Group
Pre-Injury Baseline Injury

40 0.54*
9 0.41*
7 0.59*
24 0.55*
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Grade 1 or 2 Concussion
2 0.23*
Grade 3 Concussion
12 0.63*
Note. All effect sizes were converted to the same scale with positive effect sizes
indicating worse outcomes; d = Cohens’ d; k = number of included studies; FSIQ = Full
Scale IQ; PIQ = Perceptual IQ; VIQ = Verbal IQ; Effect sizes with asterisks indicate that
the authors found the effect size to be significantly greater than zero
Many of the included studies made other sub-group comparisons that were not listed
a
Frenchman reported Hedge’s g, not Cohen’s d.

heterogeneity was present, as evidenced by an extreme range of observed effect sizes (d
ranged from -.41 to .82) and large standard deviations (SDd = .17; SDg = .18).
Significantly, excessive between-study heterogeneity can impede ability to draw accurate
conclusions (Greco, Zangrillo, Biondi-Zoccai, & Landoni, 2013; Greenland, 1987).
Furthermore, this heterogeneity suggests the possibility that effect modifiers, or
covariates, are likely to be contributing to variability between studies.
Approximately 10 years later, Frenchman, Fox, and Mayberry (2005) updated
Binder and colleagues’ (1997) meta-analysis by including seventeen additional studies. It
was determined that MTBI has a small negative overall effect on neurocognitive
functioning (g = .32). This study also considered whether time since injury moderated
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changes in neurocognitive functioning. A moderate effect size (g = .33) was observed
during the acute stages of recovery (< 3 months) and there was a small, non-significant
effect size in the post-acute stage (g = .11). To analyze the effect of time, the researchers
performed a subgroup comparison, stratifying the studies by the covariate, time (acute
versus post-acute). Two separate estimates of effect size, one for acute MTBI and one for
post-acute, were computed. Although this approach is common in systematic reviews, the
method of conducting multiple sub-group comparisons increases the risk of Type I errors
(Cafri, Kromrey, & Brannick, 2010; Wang, Lagakos, Ware, Hunter, & Drazen, 2007).
Published the same year as Frenchman and colleagues’ (2005) meta-analytic
review, Belanger and colleagues also examined the effects of time, as well as other
possible moderators, on neurocognitive outcomes post-MTBI (Belanger, Curtiss, et al.,
2005). Thirty-nine articles published between 1970 and 2004 were identified that
examined the neurocognitive effects of sustaining an MTBI in a medical-seeking
population (i.e., non-athletes). The authors reported a medium overall effect size (d =
.54), with small to medium effect sizes across nearly all cognitive domains. To explore
the potential influence of additional moderators, sub-group analyses were conducted by
stratifying neurocognitive domains by time post-injury (< 90 days, ≥ 90 days) and sample
characteristics (litigation-based samples, clinic-based studies, unselected sample studies).
These analyses showed that, generally, for the non-litigant studies, the effect sizes failed
to reach significance after 90 days, whereas the effect sizes for the litigant-based studies
tended to increase over time. While the researchers’ decision to stratify the sample by
post-injury time intervals and sample selection shed invaluable insight into the
differences in recovery across different populations, the Q statistic (a measure of
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between-study heterogeneity) still reached significance across most of these sub-group
analyses, suggesting not all meaningful moderators were explored. Furthermore, the
process of stratification meaningfully depleted the number of studies included in each
sub-group analysis. For example, only two studies included a litigation-based sample in
the acute recovery period, which calls into question the precision of the observed effect
size.
Belanger and Vanderploeg (2005) conducted an additional meta-analytic review
analyzing the effects of MTBI on athletes. A medium effect size was observed across all
cognitive domains (d = .49). They also investigated the moderating effect of time by
performing three subgroup analyses during the acute period of recovery (within 24 hours,
1-7 days, and beyond 7 days). Unlike the medical-seeking population from the previous
analysis, the neurocognitive effects of MTBI resolved in nearly all domains after seven
days for the athlete populations included in this study. In addition, likely due to a practice
effect, studies that utilized a pre-post comparison design resulted in effect sizes nearly
half as large as the effect sizes derived from studies using a non-concussed control group.
Notably, again, these sub-group analyses resulted in a smaller number of studies included
in each analysis and the Q statistic remained significant, suggesting the influence of
additional moderators.
Several additional meta-analytic studies have examined the neuropsychological
effects of sustaining an MTBI in various populations (Green, 2013; Konigs, de Kieviet, &
Oosterlaan, 2012; Pertab, James, & Bigler, 2009; Rohling et al., 2011). Generally,
researchers have found that cognitive residuals resolve in less than three months postinjury. However, various moderator variables (e.g., litigation status, study methodology)
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result in different effect size estimates. Despite attempts to explore these moderator
variables, significant between-study heterogeneity generally remains, even when multiple
subgroup comparisons are made (e.g., Belanger, Curtiss, et al., 2005). Thus, the field
would benefit from an updated analysis that further explores moderator variables and
attempts to control for between-study heterogeneity.
Meta-Regression
Meta-analytic methodologies are continuing to evolve and may be useful in
addressing some of the issues previously described. Specifically, meta-regression
analysis (Stanley & Jarrell, 1989) can control between-study heterogeneity,
systematically test the significance of effect modifiers, or covariates, and quantify their
effect on the effect size estimator. This method would address several limitations
associated with prior meta-analytic reviews of MTBI, such as the significant betweenstudy heterogeneity and the decrease in k due to multiple sub-group comparisons.
Similar to meta-analytic reviews, meta-regression has increased power to detect
small effect sizes and yields results that are more likely to generalize than findings from a
single study. The clear advantage of meta-regression is the ability to control for
significant between-study heterogeneity. This is done by investigating whether covariates
meaningfully impact effect size differences in regression models. Thus, researchers can
simultaneously consider the effect of the covariates on neurocognitive recovery without
having to conduct subgroup comparisons. As an example, a meta-analysis examining the
relative risk of contracting tuberculosis (TB) after inoculation with a BCG vaccine
included 13 studies and identified that the risk ratio of contracting TB was 0.65 (Colditz
et al., 1994). Considerable heterogeneity was present among the studies and risk ratios
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varied from .20 to 1.56 (Q(12) = 152.23, p < .0001). It was hypothesized that the vaccine
would be more effective in colder climates because individuals living farther away from
the equator would have a weaker, natural immunity to TB. A meta-regression was
conducted to further explore this issue with latitude identified and added as a covariate to
the model (Berkey, Hoaglin, Mosteller, & Colditz, 1995). Latitude was a significant
covariate with the risk ratio of contracting TB with a BCG vaccine decreasing in
effectiveness as distance from the equator increased. Remarkably, latitude accounted for
79% of the between-study heterogeneity. Meta-regression methods are also useful in
examining the magnitude a study characteristic has on an effect size. For example, a
meta-regression was conducted to examine the dose-response effect of prophylactic
aspirin and secondary stroke prevention (Johnson et al., 1999). The authors investigated
if the relative risk of secondary stroke was altered with different doses of aspirin in a
single analysis, rather than performing multiple subgroup analyses based on dose-size.
The authors found that a flat (i.e., linear) dose-response curve in stroke prevention
suggests that all doses of aspirin in the model similarly prevented subsequent strokes.
To date, only one study has examined the neurocognitive effects of MTBI
utilizing meta-regression to address issues associated with between-study heterogeneity
(Dougan, Horswill, & Geffen, 2014). Overall, Dougan and colleagues’ analyses (k = 91)
identified a small to moderate decrease in neuropsychological functioning (d = .40),
moderate to large increase in self-reported symptoms (d = .66), and a small effect in
balance disturbance (d = .11) was associated with concussion.1 Meta-regression analyses

1

The study reported negative effect sizes to represent greater dysfunction. However, the direction of the
effect sizes were reversed to remain consistent with the direction of the effect sizes reported in the previous
studies. As such, the direction of the beta values for the reported regression were also reversed.
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were conducted separately to control for time since injury, age, and education. The first
regression analysis showed that the overall dysfunction associated with a concussion
decreased over time (β = -.06), which suggests that a moderate to large effect of
concussion would be observed in the first 24 hours but would decrease to a small to
moderate effect after 10 days. This analysis, however, did not account for all the
between-study heterogeneity and the Q statistic remained significant. Negative
relationships between the neuropsychological effects of concussion and age (β = -.11)
and education (β = -.20) were additionally reported. After controlling for these variables,
the between-study heterogeneity reported in these two analyses (i.e., Cochran’s Q) was
no longer significant. While this study is the first of its kind to use a meta-regression to
better explain changes in neuropsychological functioning after MTBI, only a SRC
literature was analyzed. Thus, our understanding of the neuropsychological effects of
sustaining an MTBI would further improve if a more inclusive meta-regression were
conducted that included a broader literature and considered additional moderator
variables.
Present Study
MTBI is a significant public health crisis, affecting millions of individuals in the
US each year (Faul et al., 2010). There is considerable variability in presentation and
duration of the cognitive, physical, and emotional symptoms that occur post-MTBI.
Furthermore, there are cognitive, psychological, emotional, and demographic factors that
potentially influence the extent of dysfunction and the duration of recovery (e.g., Fann,
Uomoto, & Katon, 2001; Goleburn & Golden, 2001). Given the range of individual
differences that could potentially affect MTBI recovery, a well-conducted quantitative
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analysis of a broad literature would be of great value to clinicians and researchers. While
several meta-analyses have been conducted examining the cognitive effects of MTBI (see
Table 2), these studies have some notable methodological limitations (e.g., between-study
heterogeneity, decreased power due to multiple sub-group comparisons). Meta-analytic
regression addresses some of these limitations and may be useful in understanding how
individual differences affect cognitive recovery after an MTBI.
A comprehensive, updated meta-analytic review was conducted that incorporated
the largest number of published studies pertaining to MTBI, to date. Furthermore, this
research utilized meta-regression techniques to control between-study heterogeneity and
systematically test the direct influence of effect modifiers. The information garnered from
these analyses has the potential to inform clinical care by establishing patient prognosis
based on a host of individual differences.
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Primary Aims
Aim 1: Conduct an updated meta-analysis examining the neuropsychological effects of
sustaining an MTBI across heterogeneous populations.
A significant body of literature makes clear that the acute neurocognitive effects
of a single MTBI largely diminish three months post-injury (e.g., Belanger, Curtiss, et al.,
2005). Yet, several factors may contribute to documented variability in recovery. Thus, a
primary aim of this study is to conduct an updated meta-analysis to elucidate how effect
modifiers (e.g., population, age, psychological comorbidities, and performance invalidity)
may affect MTBI recovery.
Hypothesis 1: Consistent with the previous literature, a medium overall effect is expected
in the acute period post-MTBI that will fail to reach significance after three months.
Hypothesis 2: It is expected that (a) effect sizes will differ across the different
“populations;” (b) effect sizes will not differ for the different age groups (c) effect sizes
will differ for individuals with psychological comorbidities (d) effect sizes will differ for
studies where effort testing is implemented
Hypothesis 3: Despite stratifying by these different effect modifiers and performing
multiple sub-group analyses, it is hypothesized that between-study heterogeneity will still
exist.
Aim 2: To conduct a meta-regression to control for potential between-study heterogeneity
and quantify the effect of covariates has on the neuropsychological functioning postMTBI.
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Previous meta-analyses have documented that between-study heterogeneity is
evident despite efforts to control for this variability via multiple sub-group comparisons.
Thus, a meta-regression will be useful to examine the neurocognitive effects of sustaining
an MTBI while controlling for this potential variability. Additionally, it will allow for the
systematic testing of each effect modifier to determine if specific covariates affect
estimated effect sizes. If so, the meta-regression will quantify the extent that each
covariate affects the estimated effect size.
Consistent with Hypothesis 2, it is hypothesized that time since injury,
psychological comorbidities/psychological functioning, and the utilization of PVTs will
affect the estimated effect sizes of neuropsychological dysfunction post-MTBI. However,
as outlined in the sections above, the unique between-study differences in findings across
populations may be a result of the intersection of external (e.g., secondary gain) and
internal factors (e.g., psychological comorbidities/psychological functioning). Thus, once
the unique variance of time since injury, psychological comorbidity, and PVT testing are
controlled, group membership (i.e., population) may not be an important predictor of
MTBI outcome.
Hypothesis 4: When entered into a meta-regression, time since injury, psychological
comorbidities, and PVT testing will be significant covariates. Effect sizes are expected to
decrease over time but increase in the presence of psychological comorbidities and
increase if PVTs are not implemented. Whereas, population and age will not reach
significance.
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Methods
Institutional Review and Best Practice Guidelines
The present study did not require direct intervention or interaction with human
subjects, nor was personal, private information identifiable during the systematic review
process. Therefore, this study was exempt from institutional review (Electronic Code of
Federal Regulations, 2018; Part 46 – Protection of Human Subjects). In accordance with
best-practice guidelines, the study was prepared in accordance with the PRISMA
statement guidelines (Moher, Liberati, Tetzlaff, & Altman, 2009). Search criteria,
selection criteria, and proposed analyses were pre-registered on a publicly available,
online database (PROSPERO Registration Number: CRD42018099719).
Literature Search and Inclusion Criteria
Consistent with previous meta-analyses (e.g., Belanger, Curtiss, et al., 2005;
Dougan et al., 2014), the internet databases PsychINFO, Medline, and PUBMED were
utilized to identify relevant studies. To maximize the number of pertinent articles and
decrease the number of non-relevant studies, key terms were entered into the databases as
follows: (“Mild Traumatic Brain Injury” OR “MTBI” OR “Concussion” OR “Mild Head
Injury”) AND (Neuropsycholog* OR Assess* OR Evaluat* OR Cogniti*)2. Furthermore,
to ensure pertinent articles were not overlooked, the reference from prior MTBI metaanalyses were also reviewed. The initial literature search was conducted November 2017.

2

The asterisk (*) at the end of the truncated search term allows for the simultaneous search of multiple
iterations of the word. For example, neuropsych* searchers for neuropsychology and neuropsychological.

33
Table 3.
Inclusionary and Exclusionary Criteria for Article Selection
Inclusionary Criteria:
• Published in English
• Involved human research subjects
• MTBI or concussion was clearly defined and consistent with the ACRM, WHO
Task Force, or International conference on Concussion in Sports criteria
• Included if the neuropsychological performance of an MTBI group is compared
to pre-injury self, non-concussed control group, or orthopedic injury or pain
control group
• Included if the study utilized standardized and validated neurocognitive
measures (e.g., Lezak, 1995; Strauss, Sherman, & Spreen, 2006) to assess
cognitive functioning
Exclusionary Criteria:
• Insufficient information to calculate effect sizes
• Average age of participants is not provided
• Sample size of each group is less than 10
• Case study
• Non-empirical study
• Meta-analysis
• Systematic review
• Intervention study
• Participant recruitment based on neuropsychological normality or impairment
• If average time since injury is not reported or if average time since injury of the
study participants is greater than three years
• If sample includes subjects with complicated (e.g., intracranial hemorrhage,
skull fracture) TBI

Briefly, empirical studies were included if an MTBI occurred and well-validated
neuropsychological assessments were utilized to document cognitive functioning within
three years from the initial injury. Articles were excluded if there was insufficient
information to calculate or estimate effect sizes (See Table 3 for full inclusionary and
exclusionary criteria). Additionally, if data for all cognitive outcome measures were not
reported, the study was excluded. That is, studies were excluded if the authors only
provided data for the significant, but not the non-significant findings. If assessments took
place across multiple timepoints and the authors did not report the data from all time
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points, the study was retained so long as all data were provided for at least one time
point.
Data Extraction and Evaluation of Inter-rater Reliability
Three supervised graduate students (DM, MN, KR) conducted an initial screening
by reviewing titles and abstracts of articles obtained from the initial online search for
inclusionary/exclusionary criteria. To increase inter-rater reliability, a training session
was conducted to establish systematic and consistent screening and reviewing of article
titles and abstracts (See Appendix A for flowsheet outlining the approach to abstract
coding). A subset of articles were double-coded to establish inter-rater reliability. Of the
492 articles (8.2%) that were double-coded, inter-rater reliability was strong (kappa =
.887). Discrepancies and uncertainty in article coding were resolved via a consensus
conference among the reviewers and a licensed psychologist (JH).
After initial review of the articles, the full text documents were further screened
for inclusion/exclusion criteria. This process was completed by the primary investigator
(DM). The same reviewers and licensed psychologist took part in data extraction, effect
size calculation, and identification of moderator variables once an article was identified
as meeting full inclusionary/exclusionary criteria. All extracted data utilized for effect
size calculations were double coded for accuracy by supervised research assistants.
Variables of Interest
While this study was inherently exploratory in nature, all variables of interests
were selected a priori and listed with the open-access systematic review registry,
PROSPERO. This was done to reduce potential bias and prevent p-hacking (i.e.,
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conducting multiple analyses until statistical significance was found). Variables of
interested are detailed below.
Cognitive Outcome Measures. Consistent with previous meta-analyses
(Belanger, Curtiss, et al., 2005; Belanger & Vanderploeg, 2005; Dougan et al., 2014;
Frencham et al., 2005; Rohling et al., 2011), tests were grouped in a manner that is
consistent with neuropsychological literature (Lezak, 1995; Strauss, Sherman, & Spreen,
2006). Nine outcomes based on cognitive domains were created: (1) general ability/IQ;
(2) orientation; (3) language abilities/academic achievement; (4) attention/working
memory; (5) processing speed; (6) executive functioning; (7) immediate memory; (8)
delayed memory; (9) fine motor movement. The effect sizes of all cognitive outcome
measures were also aggregated via arithmetic mean to create a single, “Overall” effect
size to represent the total cognitive sequalae of sustaining an MTBI.
Diverging from the precedent of most other MTBI meta-analyses (c.f., Pertab et
al., 2009), only validated neurocognitive assessments frequently used in clinical practice
that measured the cognitive domains outlined above were selected for analysis . This was
done to increase the internal consistency within cognitive domains. In addition, this
ensures that a lack of between-group differences in cognitive recovery does not reflect
experimental test construction and unknown psychometric properties. For example, in an
imaging study conducted 37 days post-injury, performance differences were not observed
between patients medically referred for treatment of MTBI and a control group for a
working memory task used during neuroimaging; however, in the same study significant
differences were found in a well-established task of attention and working memory
(McAllister et al., 2011). A measure was considered “validated” if (1) the measure is
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referenced by well-established sources of psychological assessment (Lezak, 1995; Strauss
et al., 2006); or (2) if relevant validity studies have been published in referred journals. If
a study included both validated and non-validated assessment measures, the study was
retained and only the validated measures were included in the analysis.
Moderator Variables. This study sought to determine if effect modifiers, or
covariates, affect cognitive recovery from MTBI. Specifically, the primary covariates of
interest are: time post-MTBI, population (e.g., athletes, Veterans, general medical
referrals, litigants), age, psychological comorbidities, and if the study used PVTs to
exclude non-credible performance. Given that Aim 1 analyses utilize categorical
variables, continuous moderator variables were also coded categorically for these
analyses (See Appendix B for the data code sheet for additional information).
Time since Injury. For pair-wise comparisons (Aim 1), time since injury was
coded categorically into five discreet time strata: 1) ≤ 24 hours; 2) 1-8 days; 3) 9-30 days;
4) 31-90 days; and 5) > 90 days. These timepoints were selected for consistency with
documented neurometabolic and neurophysiological recovery periods post-MTBI (Giza
& Hovda, 2001), and with the assessment intervals commonly used within the empirical
literature. The mean time since injury was coded as a continuous variable for metaregression analyses (Aim 2).
It is common that studies report outcomes for multiple time points when the study
participants are followed longitudinally. However, inclusion of multiple time points from
a single study in a given analysis biases the overall calculation of the observed effect size
as that study is given more weight than other studies with a single time point. It is
uncertain, however, how multiple timepoints were handled in previous MTBI meta-
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analyses. To our best knowledge, previous studies created a single outcome by averaging
these timepoints together. However, important variability regarding cognitive recovery is
potentially lost by this method. For example, if a study found a large effect size (d = 1.00)
in the first 24 hours after an injury and a small, non-significant effect size one year after
the injury (d = .01), the mathematic average would give the potentially erroneous
conclusion that a medium effect size (d = .50) was found after 6 months. To prevent
studies with multiple outcomes from unduly biasing the overall results, only a single time
point per time strata was utilized in each analysis
In an effort to reduce bias and preserve important variability, an arithmetic
average across timepoints was not utilized. For Aim 1, multiple timepoints were analyzed
separately based on their respective time stratum (i.e., ≤ 24 hours, 1-8 days, 9-30 days,
31-90 days, and > 90 days). However, if a study reported multiple outcomes that fell
within a given time strata, the furthest timepoint with (presumably) the smallest effect
size was selected for analysis. For example, Kontos and colleagues (2016) reported
outcomes for three time points within the “9-30 day” window (14 days, 21 days, and 28
days). Therefore, the data from the furthest time point (28 days) was retained for pairwise
analyses.
For Aim 2, time since injury was analyzed as a continuous variable. Therefore,
multiple time points could not be analyzed separately. To avoid the issues involved with
averaging multiple time points as done by other studies, only the furthest time point was
retained for analysis. For example, Nelson and colleagues (2016) reported outcomes for
four time points post-injury: < 24 hours, 8 days, 15 days, and 45 days. Only the data from
45 days post-injury was retained for analysis. The rationale for selecting the furthest time
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point was two-fold: (1) in the very acute stages of MTBI, the extent of cognitive
dysfunction appears to be similar across populations (McCrea et al., 2014) and (2) a
primary objective of this project is to determine moderating factors of cognitive recovery
post-MTBI, and not necessarily the acute effects of sustaining an MTBI.
Population. For both the pair-wise analysis and the meta-regression, population
were coded as a categorical variable (Athlete, General Medical Referral, Veteran, and
Litigant). While we acknowledge the inherent medicolegal nature of neuropsychological
assessments with Veterans, any Veteran sample was coded as “Veteran” even if the
sample consisted of individuals involved in a compensation/disability evaluation. Even if
it represented a minority of the participants, a study was coded as “litigant” if it included
any participants who were involved in litigation or seeking compensation for their injury.
Age. The average age of the study sample was coded in two ways: categorically
(children, high school and college, adult, older adults; Aim 1) and as the mean age of the
sample (Aim 2). Study samples with an average age of 0-13 years of age were coded as
“children,” samples with a mean age between 14-22 were coded as “high school and
college,” samples with a mean age between 23-64 were coded as “adults,” and samples
with an a mean age of 65+ were coded as “older adults.”
Psychological Comorbidity and Functioning. Similar to age, psychological
comorbidities were coded both categorically (Aim 1) and continuously (Aim 2). If the
entire sample had the presence of a psychological comorbidity, it was coded as “100%
psychological comorbidity,” whereas, if the study explicitly excluded study subjects with
psychological comorbidities, it was coded as “0% comorbidity.” Any sample percentage
in between the two was be coded as “mixed.” If the study did not specifically state that

39
psychological comorbidities were assessed or screened, the study was conservatively
labelled as “mixed.”
If questionnaires assessing emotional well-being and personality were reported,
the effect sizes of mood disturbance relative to the control group were calculated in the
same manner as the cognitive constructs (see Effect Size Calculation for methodology).
Initially, psychological functioning was stratified into separate psychological constructs
(depression, anxiety, PTSD, SUD, somatization, internalizing behaviors, externalizing
behaviors). While there may be different effects across various psychological constructs a
single “Overall” psychological functioning variable was created to increase power and
conciseness. This variable was intended to capture the overall extent of psychological
distress experienced by the MTBI samples relative to the controls, and it was created via
arithmetic mean of the effect sizes across psychological constructs and is the primary
moderator variable of psychological functioning for meta-regression analyses (Aim 2).
Performance Validity Testing and Effort. Studies that utilized embedded and/or
freestanding PVTs to identify and exclude study participants with sub-optimal task
engagement were coded categorically (effort screened; effort not screened).
Secondary Moderator Analyses. Much like simple linear regression, there must
be a sufficient ratio of covariates to data points to include multiple moderator variables in
an analysis. That is, it is recommended that there be at least 10 studies included in a
meta-regression analysis for every covariate (Borenstein et al., 2009). As a result, this can
limit the number of covariates considered. The following additional moderators were
coded for supplemental, exploratory analyses.
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Post-Concussive Symptomology: The presence of post-concussive symptomology
(PCS) was coded in a continuous manner. An effect size of PCS symptomatology was
calculated when questionnaires were given to both the MTBI and control groups (See
Effect Size Calculations for methodology).
Control group. The control group implemented by researchers may affect the
observed outcomes (Belanger & Vanderploeg, 2005; Dougan et al., 2014). Some studies
attempt to control for extraneous variables such as pain or psychological distress when
assessing the cognitive sequelae of an MTBI. These studies tend to lead to a more
conservative effect size estimate than studies that utilize healthy, non-injured participants
as controls. Therefore, the type of control group (non-injured control, pre-injury baseline,
non-injured control & pre-injured baseline, orthopedic injury, trauma, chronic pain) was
documented.
Injury Parameters. If provided by the author, the percentage of individuals who
experienced LOC, post-traumatic amnesia, and/or a prior MTBI were also coded.
Demographics. Given that demographic factors such as race (Shafi et al., 2007),
sex (Bazarian, Blyth, Mookerjee, He, & McDermott, 2010), and education (Dougan et al.,
2014) may affect cognitive recovery, pertinent demographic information was also
recorded when available.
Effect Size Calculations
As most data from MTBI neuropsychological outcomes studies are continuous, all
dependent variables were converted into the effect size, Cohen’s d, as is convention for
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studies in this field3 (Belanger, Curtiss, et al., 2005; Belanger & Vanderploeg, 2005;
Binder et al., 1997; Dougan et al., 2014; Konigs et al., 2012; Pertab et al., 2009; Rohling
et al., 2011; c.f., Frencham et al., 2005). If another effect size were provided (e.g.,
Pearson correlation, r), it was converted into Cohen’s d following standardized processes
(Lipsey & Wilson, 2000). Likewise, in the absence of group means or calculated effect
sizes, the inferential statistics reported by the authors may also be used to estimate the
effect size (Lipsey & Wilson, 2000).
Effect sizes were calculated in accordance with well-established methods outlined
by Lipsey and Wilson (2000). Effect size calculation differed based on the study design
utilized by the authors, which fell into one of three categories: 1) two independent groups
2) repeated measures design and; 3) independent groups with repeated measures.
Independent Groups, Post-Test Only. The standardized mean difference
between two independent groups was calculated based on the following equation:
𝑑=

𝑀𝐶𝑜𝑛𝑡𝑟𝑜𝑙 − 𝑀𝑇𝐵𝐼
𝑆𝐷𝑃𝑜𝑜𝑙𝑒𝑑

(1)

Where the 𝑆𝐷𝑝𝑜𝑜𝑙𝑒𝑑 is the pooled standard deviation and was calculated as:
(𝑛1 −1)𝑆𝐷12 +(𝑛2 −1)𝑆𝐷22

𝑆𝐷𝑝𝑜𝑜𝑙𝑒𝑑 = √

𝑛1 + 𝑛2 −2

(2)

The standard error of the effect size estimate (𝑆𝐸𝑑 ) was calculated as:

While most meta-analyses in this field utilize Cohen’s d, there are some criticisms of this methodology as
Cohen’s d is a biased effect size estimate (Lakens, 2013). Rather, some researchers report Hedges g as it
attempts to correct for bias (e.g., Frenchman et al., 2005). However, when sample sizes are large (n > 20)
the difference between the two effect sizes are negligible (Lakens, 2013). Given that we expect a large k
with large sample sizes, we expect there to be no meaningful differences between Cohen’s d and Hedges g.
3
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𝑛 + 𝑛2

𝑆𝐸𝑑 = √( 𝑛1

1

𝑛2

)+

𝑑2

(3)

2(𝑛1 + 𝑛2 )

Repeated Measures (Same Sample) Design. In this dependent-sample design,
the post-injury scores of the participants are compared to their own pre-injury baseline
scores, resulting in a standardized change score (compared to a standardized difference
scores produced from the other designs). The formula for the standardized change is
calculated as follows:
𝑑𝑅𝑀 =

𝑀𝑑𝑖𝑓𝑓
√𝑆𝐷12 +𝑆𝐷22 −2𝑟(𝑆𝐷12 +𝑆𝐷22 )

𝑥 √2(1 − 𝑟)

(4)

where 𝑀𝑑𝑖𝑓𝑓 is the mean difference in scores between time 1 and time 2, and r is the
correlation between time 1 and time 2. The standard error of 𝑑𝑅𝑀 is calculated by the
following equation:
1

𝑆𝐸𝑑𝑅𝑀 = √(𝑛 +

𝑑2
2𝑛

) 2(1 − 𝑟)

(5)

Notably, these formulas require both the average change scores as well as the correlation
between the two time points, both of which are rarely provided by the authors. When
correlations are not provided, it is recommended to estimate the correlation from similar
studies (Borenstein et al., 2009). However, studies where such information are provided
(i.e., test-retest reliability, reliable change studies) typically sample from a healthy, noninjured pool of participants (c.f., Nelson, LaRoche, et al., 2016). Thus, those correlations
are unlikely to resemble the true correlation in testing outcomes in an MTBI sample
where the scores are expected to change across time.
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Other formulas that do not require average change scores or correlations have
been proposed (Becker, 1988; Morris & DeShon, 2002). These formulas utilize either the
pre-injury standard deviation (Becker, 1988) or pool the standard deviations from both
time points (Morris & DeShon, 2002). However, these methodologies have been found to
result in larger estimated effect sizes (Belanger & Vanderploeg, 2005; Dougan et al.,
2014) and are susceptible to maturation and practice effects. Finally, most studies
utilizing this design involved athletes; it is rare that baseline testing is obtained in nonathlete populations. Thus, to ensure consistence in study designs across all populations,
the formula proposed by Lipsey and Wilson (2000), which requires the correlation
between the two time-points, was utilized. Notably, this methodological decision resulted
in the exclusion of most of the repeated measures study designs.
Independent Groups with Repeated Measures. Likely the most robust
experimental design, the pre-post design with independent groups accounts for any
potential practice effects from repeated testing. The effect size is calculated by
subtracting the standardized difference of the control group from the standardized
difference of the injured sample via the following equation:
𝑑=

(𝑀𝐶𝑜𝑛𝑡𝑟𝑜𝑙 𝑇2 − 𝑀𝐶𝑜𝑛𝑡𝑟𝑜𝑙 𝑇1 )− (𝑀𝑀𝑇𝐵𝐼 𝑇2 − 𝑀𝑀𝑇𝐵𝐼 𝑇1 )
𝑆𝐷𝑃𝑜𝑜𝑙𝑒𝑑 𝑇2

(6)

where 𝑆𝐷𝑃𝑜𝑜𝑙𝑒𝑑 𝑇2 is calculated the same manner as Equation (2); that is, the standard
deviation is pooled from the MTBI and control group post-injury outcomes. The 𝑆𝐸𝑑 for
the independent group with repeated measures design is calculated the same way as
Equation (3) where the post-injury sample sizes are used.
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Outlier Analysis
Publication bias, the non-random exclusion or absence of studies, can lead to
outlying study effects. One source of publication bias is the small-study effect (Greco et
al., 2013). The small-study effect occurs when smaller studies tend to systematically have
different effect sizes than larger studies. This may be due to differences in methodology
where smaller studies are less methodologically sound than larger, well-funded studies;
or, due to a file-drawer effect, where smaller studies with null findings are less likely to
be published (Greco et al., 2013). Due to the smaller sample size of these studies, there is
greater variability which can lead to an inflation in reported effect sizes compared to
larger studies (Sterne, Gavaghan, & Egger, 2000; Sterne, Egger, & Smith, 2008).
To assess for publication bias, a funnel plot was constructed and visually
inspected (Bartolucci & Hillegass, 2010). A formal test of asymmetry in the funnel plot
was conducted via Egger’s Regression Intercept (Egger, Smith, Schneider, & Minder,
1997), which uses linear regression to measure the degree of bias seen from the small
study effect. As asymmetry increases, the intercept of the line deviates from 0. This test
determines if the intercept is significantly different from 0.
To determine the extent that the file-drawer effect may be problematic, a Fail Safe
File Drawer analysis (Rosenthal, 1979) was also calculated. This analysis calculates the
number of unpublished studies necessary to offset the obtained effect size estimate. If a
relatively small number of studies are needed to offset the obtained effect size, there is
likely a file-drawer effect. However, if many studies are needed to offset the potential
results, then a file-drawer effect is less likely.
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Data Analysis
Effect sizes were derived from each study with an Excel program developed by
the primary investigator (DM). This program incorporated the methodological
calculations outlined by Lipsey and Wilson (2000) and is freely available to the public
(https://www.marquette.edu/psychology/frl-neuropsychology-and-personality-lab.php).
The pairwise and meta-regression analyses were conducted utilizing Comprehensive
Meta-Analysis Version 3 software (Borenstein, Hedges, Higgins, & Rothstein, 2016).
Individual effect sizes from each study were aggregated and weighted based on
the following equation:

𝑑=

∑ 𝑤𝑖 𝑑𝑖
∑ 𝑤𝑖

(7)

where 𝑑𝑖 is the effect size estimate of a particular study and 𝑤𝑖 is the weighted variance.
The way in which 𝑤𝑖 is calculated depends on whether a fixed-effect or a random-effect
is being calculated.
Previously published MTBI meta-analytic studies conducted fixed-effect
analyses. A fixed-effect meta-analysis assumes that there is one true effect size and the
various studies included in the analysis are estimating that effect size. It assumes that the
included studies are a random sample of a relevant distribution of effects, and that the
calculated effect size is an estimate of the mean effect of said distribution. Furthermore,
all factors that could potentially influence the effect size are the same across all study
populations (Borenstein et al., 2009). Thus, the only source of error observed when
calculating the overall weighted effect size is the random error found within studies. In
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contrast, the current study conducted random-effects analyses. A random-effects model
assumes that the true effect size varies from study to study (Borenstein et al., 2009). The
studies included in the meta-analysis are assumed to be a random sample from a relevant
distributions of true effects, rather than a distribution of a single effect, as in the case of
fixed-effects. Thus, there are two sources of error: the within-study error and betweenstudy error.
All prior MTBI meta-analyses conducted fixed-effect analysis (e.g., Dougan et
al., 2014). However, the purpose of the present study is to determine the extent that
moderator variables (i.e., population, age, psychological comorbidities, PVT
performance) affect cognitive recovery after sustaining an MTBI. It was hypothesized
that some of these modifiers would influence the overall effect of an MTBI. It would be
illogical, therefore, to conduct a fixed-effect meta-analysis given that we do not assume
there is one “true” effect size associated with MTBI. Thus, a random-effects metaanalysis was selected as the primary analytical method. The rest of this section elaborates
upon methodological issues that are specific to each Aim.
Aim 1. An updated meta-analysis examining the neuropsychological effects of
sustaining an MTBI across heterogeneous populations was conducted. Consistent with
the approach utilized in prior MTBI meta-analyses, multiple sub-group comparisons were
conducted. A random-effects analogue-to-ANOVA was conducted to examine
differences in observed effect sizes across cognitive domains (e.g., processing speed,
immediate memory, executive functioning), populations (athletes, general medical
referrals, Veterans, litigants), ages (children, high school and college, adults, older
adults), the presence of psychological comorbidity (none, mixed, 100%), and if effort was
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systematically evaluated. Multiple comparisons were made to determine if the estimated
effect size is significant in the acute phases (≤ 24 hours,1-8 days), sub-acute phases (9-30
days, 31-90 days) and the post-acute phase (> 90 days) after sustaining an MTBI. For the
sake of parsimony and to reduce Type I errors, all moderator analyses were conducted
utilizing the Overall cognitive functioning variable.
To assess for between-study heterogeneity, or a wide distribution of observed
effect sizes not due to chance, Cochran’s Q was calculated. Cochran’s Q, which follows a
Chi square distribution is calculated as follows:
𝑄 = ∑ 𝑤𝑖 (𝑑𝑖− 𝑑̅ )2

(8)

where 𝑑̅ is the mean calculated effect size and 𝑑𝑖 is the effect size of the ith study. A
smaller Q statistic suggests a lack of heterogeneity (Bartolucci & Hillegass, 2010)
whereas a larger Q statistic suggests that the variability in observed effect sizes cannot be
explained by random sampling error, alone. Notably, some researchers posit that due to
differences in methodology and the demographic composition of various studies,
heterogeneity is inevitable (Higgins, Thompson, Deeks, & Altman, 2003). Thus, another
index for heterogeneity is 𝐼 2 , which measures the impact of the heterogeneity on metaanalytic results, rather than attempting to detect it as Cochran’s Q does. This variable,
which ranges from 0-100, provides an estimate of the variability that remains
unexplained after the analysis. 𝐼 2 was calculated as follows:

𝐼2 = (

𝑄−𝑑𝑓
𝑄

) ∗ 100

(9)
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where higher values of 𝐼 2 indicates more variability in effect size estimates due to
heterogeneity, rather than random, sampling error.
Aim 2. A random-effects meta-regression was conducted, which was modelled as
follows:
𝑦𝑖 = 𝛽0 + 𝛽1 𝑥1𝑗 + 𝛽2 𝑥2𝑗 + ⋯ 𝛽𝑖 𝑥𝑖𝑗 + 𝜀𝑗 + 𝜂

(10)

Where 𝑦𝑖 is the effect size for the ith study and 𝛽0, the Y intercept, is the estimated
overall effect size when the covariates are not considered (Berkey et al., 1995). The
covariates, 𝛽𝑖 , have the value 𝑥𝑖𝑗 for each study, j. The error terms, 𝜀𝑗 represents the
imprecision of estimating the effect size for each study, j (i.e., sampling error). 𝜀𝑗 ~ N(0,
𝜎𝑗2 ) where 𝜎𝑗2 is the within-study variance and used to estimate 𝜀𝑗 . The between-study
variability for the jth study is 𝜂𝑗 . 𝜂𝑗 ~ N(0, 𝜏 2 ) where 𝜏 2 is the is the true effect size
across studies and used to estimate between-study variable. Therefore, in a random-effect
analysis, the observed effect size has the following distribution: 𝑦𝑖 ~ N(𝑋𝑗 𝛽, 𝜏 2 + 𝜎𝑗2 ).
Based on methodology of similar meta-regressive studies (Etnier, Nowell,
Landers, & Sibley, 2006; Lee, Hermens, Porter, & Redoblado-Hodge, 2012), each effect
modifier was modeled, separately, with mean time since injury as a covariate. That is,
population, average age of sample, the effect size of psychological and personality
questionnaires, and PVT testing were modeled separately after controlling for the mean
time since injury. Significant of covariates was determined via Knapp-Hartung instead of
a Z-test as the Knapp-Hartung is more conservative, yet more accurate when using
random-effects analyses (Knapp & Hartung, 2003). Significant covariates were then
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entered into a meta-regression simultaneously. To further examine neurocognitive
recovery curves over time, linear and non-linear (quadratic) models were also conducted.
The variability explained by each predictor was calculated. Much like the
coefficient of determination in simple linear regression (i.e., 𝑅 2 ), this metric was
calculated by finding the ratio of the variance explained by the covariate and the total
variance. However, the covariates are study-level covariates, thus only providing a
measure of the between-study variability. Thus, to provide a better metric, the 𝑅 2 will
reflect a ratio of the “true” variability (i.e., between- and within-study variability)
(Borenstein et al., 2009), 𝜏 2 :

𝑅2 =

2
𝜏𝐸𝑥𝑝𝑙𝑎𝑖𝑛𝑒𝑑
2
𝜏𝑇𝑜𝑡𝑎𝑙

(9)

Power Analysis
A priori power analyses were conducted with R statistical packages (R Core
Team, 2014) using a script (Quintana, 2016) that utilizes the formulas for random-effects
meta-analytic power analyses outlined by Valentine, Pigott, and Rothstein (2010). Based
on previous meta-analyses, large between-study heterogeneity was assumed for the
power analyses. Table 4 displays the combination of different number of studies (k) and
average number of MTBI and control participants needed to detect a small effect size (d
= .20) with at least 80% power.
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Table 4
Power Analysis Displayed Minimum Number of Effects and Participants Needed to
Attain Sufficient Power to Detect a Small Effect Size
Number of
Effects
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100

Average n
Per Group
55
45
40
40
35
30
30
25
25
25
20
20
20
20
20

Power
0.82
0.80
0.81
0.84
0.84
0.82
0.85
0.81
0.84
0.84
0.81
0.83
0.85
0.86
0.88
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Results
The initial article search across databases (PsychINFO, PubMed, MedLine)
identified 8,697 studies for potential inclusion. Another 297 articles were identified from
previously published meta-analyses (38 of which were unique and not duplicates with the
primary literature search). After duplicates were removed, 6,010 titles and abstracts were
screened for potential inclusion. Of these articles, 5,361 were excluded, leaving 649
articles whose full text was reviewed for possible inclusion (Figure 2).
Figure 2.
Flow of Meta-analysis Search and Application Inclusion Criteria
Articles Identified Through Database
Searching:
PsychINFO = 3,360
Medline = 1,141
PubMed = 4,196
Total Articles: 8,697

Number of Articles Identified through
other sources:
297 articles identified from 9
previously published meta-analyses
pertinent to MTBI

345 Excluded
2,616 Duplicate Articles Removed
*Data included in another study 3
*Article cannot be located – 1
*Effect size cannot be calculated
– 109
*Insufficient information to
calculate effect size – 45
*Intervention Study – 4
*Lack of Appropriate Control
Group – 31
*Time Since Injury Not Reported
– 26
*Mean Time Since Injury > 3
years – 3
*MTBI Did not Occur – 13
*N < 10 – 13
*No Neuropsychological
Assessments – 9
*Non-standardized
Neuropsychological Assessments
– 32
*Not an Empirical Study – 4
*Presence of Complicated MTBI
– 36
*Unselected Study Sample – 12
*Participants Selected Based on
Cognitive Abnormality - 3
K = 195 Athlete & General
Medical Referral Studies Not
Further Evaluated for
Inclusion/Exclusion Criteria

6,010 citations (titles and abstracts)
screened for relevance

649 Full Text Articles Randomly
Sampled and Assessed for Full Text
Eligibility

K = 109 Studies Included for Analysis
(125 independent samples)
k = 45 General Medical Referrals
k = 45 Athletes
k = 14 Litigant
k = 5 Veterans

5,361 Excluded
*Animal study - 39
*Case Study/Case Series – 207
*Commentary/Editorial – 146
*Duplication – 107
*Insufficient Information/Incomplete
Citation – 177
*Intervention/Experimental Study – 149
*Lack of Appropriate Control Group –
718
*Mean Time Since Injury > 3 yrs – 8
*MTBI Did Not Occur – 465
*MTBI Not Defined – 42
*MTBI Not Primary Focus of Study – 585
*N < 10 for each group – 28
*No Neuropsychological Assessment –
1248
*Not an Empirical Study – 1245
*Systematic Review/Meta-Analysis – 197
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Despite careful cultivation of search terms and stringent inclusionary and
exclusionary criteria, the recent explosion in the MTBI literature resulted in a much
larger pool of potential studies than anticipated. For example, the final sample of studies
aggregated across all sources was nearly six times larger than the largest MTBI metaanalysis published to date (1,243 vs. 6,010; Dougan et al., 2014). Similarly, there were
200 more papers whose full text was reviewed for inclusionary criteria compared to the
largest previous meta-analysis (420 vs. 649). In order to limit the scope of the project,
while maintaining an ability to evaluate primary aims and maintain adequate power, the
decision was made to randomly select studies for detailed review until a pre-determined
number (k = 45) of studies for each population sub-group met inclusionary criteria.
Articles were selected based on population (rather than other moderator variables of
interest) as a primary aim of the study was to discern moderator variables the explain the
well-established differences in cognitive recovery across various populations (e.g., athlete
vs. GMR; GMR vs. litigants). The decision to randomly sample articles to review was
made after consultation with a meta-analytic expert who advised on study methodology
(Jackson, 2018, personal communication, May 17, 2018). While this methodology is
novel, it is defensible as a random effects meta-analysis assumes that the effects included
in the analyses are a random distribution among the true population effect. Therefore, by
randomly selecting articles for inclusion, we maintain the randomness of the distribution
among the true population effect4. As such, 45 articles met full inclusionary criteria for
the athlete and general medical referral (GMR) groups. However, only 14 studies with
individuals involved in litigation and 5 studies with Veterans met full criteria. In total,

4

This methodology deviated from the analyses that were initially proposed and registered with
PROSPERO
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109 studies met full criteria for inclusion in analyses. Fifteen studies provided data for
multiple, independent samples, yielding a total of 125 independent samples included in
the analyses (NMTBI = 5,919, NControl = 8,318). Across all studies, sub-groups, and time
points, 747 outcomes were extracted for analysis. Table 5 displays the characteristics of
the included studies.
Outlier Analysis and Publication Bias
Extreme Scores. The distribution of all 747 effect sizes from all 125 samples
were analyzed for outlying data points. Any effect size more than 3 standard deviations
from the mean of all observed effect sizes (-1.97, 2.81) were considered outliers (Dougan
et al., 2014; Hedges & Olkin, 1985; Lipsey & Wilson, 2000). Eight effects were
identified as outliers, originating from three studies (McCauley et al., 2014; Moser,
Schatz, & Jordan, 2005; Roebuck‐Spencer et al., 2012). One outlier was in the negative
direction (d = -2.05 7 days after injury; Moser et al., 2005) and the remaining seven were
in the positive direction (d ranged 3.69 to 11.48, 2 days and 404 days post-injury;
Roebuck-Spencer et al., 2012; McCauley et al., 2014). The data from McCauley (2014)
were not true marginal means, but rather means after adjusting for age, sex, and
perceived stress. In Moser (2005) only a single effect, measuring language, was found to
be an outlying effect. In the study completed by Roebuck-Spencer (2012), the study was
an independent sample with repeated measures. The effect sizes were extreme, in part,
because the control group showed significant improvement with repeated testing,
whereas the MTBI groups showed significant declines. Rather than excluding these
studies, the effect sizes were reduced to the next major cluster of non-outlying effect
sizes (Lipsey & Wilson, 2000).
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Table 5.
Characteristics of Included Studies
Sample Information
Sample
McCrea (2003)

Country

Demographic Information

Population n MTBI n Control

Control
Group

Age

Mean
Education

%
Female

Injury Parameters
%
%
%
Previous
LOC PTA
MTBI

Psych
PVTs TSI (days)
Comorbidity

USA

Athlete

94

56

NIC

20.04

14.78

0

43.2

0

0

Mixed

No

USA
USA
Australia
USA
USA
Canada
USA
USA
USA

Athlete
Athlete
Athlete
Athlete
Athlete
Athlete
Athlete
Athlete
Athlete

30
14
34
25
13
63
11
26
29

36
14
39
25
13
31
11
25
25

NIC
NIC
NIC
NIC
NIC
NIC & PIB
NIC
NIC
NIC

19.9

14.2

23

53

50

23
21.16
16.36
21.8
18.6
15.42
14.41

13.36
13.44

0
0
21
0
27.7

100
100
100

0
0
31

54.5

18.18

44.8

44.8

Mixed
Mixed
0
0
Mixed
Mixed
Mixed
Mixed
0

No
No
No
No
No
No
No
No
No

USA

Athlete

12

12

NIC

16.5

40

8.8

Mixed

Yes

USA
USA
USA
USA
Canada
Canada
Canada
Canada
Canada

Athlete
Athlete
Athlete
Athlete
Athlete
Athlete
Athlete
Athlete
Athlete

14
14
25
33
36
14
15
17
16

14
13
82
568
18
16
15
17
16

42.86
57.14
40

14.28
0

28.57

0

0

0

28.57

Mixed
0
Mixed
Mixed
0
0
0
0
0

No
no
No
No
No
No
No
No
No

Kontos (2016)b

USA

Athlete

22

10*

NIC

16.5

45

0

No

Kontos (2016)a

USA

Athlete

15

10*

NIC

16.45

47

0

No

Schatz & Sandel (2013)b
Schatz & Sandel (2013)a

USA
USA

Athlete
Athlete

37
81

37
81

NIC
NIC

0
0

Yes
Yes

Broglio (2016)

USA

Athlete

24

21

NIC

Bruce (2003)

USA

Athlete

19

19

Pica (2007)

USA

Athlete

72

Miller (2003)

USA

Athlete

60

Pontifex (2009)
Elbin (2012)
Gardner (2010)
Singh (2014)
Moser (2002)
Mrazik (2016)
Guskiewicz (1997)
Tsushima (2013)
Koehl (2016)
Hammeke (2013)
Sim (2008)
Sikoglu (2015)
Moser (2005)
McCrea (1998)
Hutchison (2011)
Moore (2017)
Baillargeon (2012)g
Baillargeon (2012)f
Baillargeon (2012)e

NIC & PIB 15.5
NIC
20.1
NIC
15.8
NIC
OI
19.78
NIC
23.36
NIC
23.4
NIC
14.8
NIC
11

14.2
9.23
8.1

20.7

21.42
35.71
10.5

17.29
16.1
8.8
4.9

0
67
0
0
0
0

36
100

14
33

92
92

16.3

54.16

0

0

0

Mixed

No

NIC

20.1

0

52.63

21.05

68.42

Mixed

No

84

NIC

16.21

0

45.9

Mixed

No

62

NIC

16.56

Mixed

No

11.09

0

10

7
90
1044
278.7
560.1
270.6
7.5
10
1
6.8
53.79
0.54
49
6.3
76.45
7
0.01
3
819
189
174
177
7
28
7
28
3
3
6.2
26.2
79.5
0.0833
7
1
6
45
1
6
50

d
0.016
0.035
0.2
0.168
0.227
0.088
0.377
-0.457
0.444
0.207
0.853
0.28
0.023
0.817
0.629
-0.087
1.1
0.189
0.186
0.147
0.151
-0.199
1.339
1.044
1.658
1.352
0.111
0.631
0.443
0.374
0.134
0.405
0.193
0.239
0.141
0.007
-0.023
0.015
0.063
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Table 5 continued.
Characteristics of Included Studies
Sample Information
Sample
Sim (2006)
McCrea (2002)
Stueland (2001)
Gardner (2012)
Virji-Babul (2013)

Country

Demographic Information

Population n MTBI n Control

Control
Group

Age

%
Female

USA
USA
USA
Australia
Canada

Athlete
Athlete
Athlete
Athlete
Athlete

14
91
14
46
12

14
1189
12
41
10

Field (2003)m

USA

Athlete

35

18

NIC

19.85

4

Field (2003)l

USA

Athlete

19

20

NIC

15.2

USA
Canada

Athlete
Athlete

132
16

38
18

USA

Athlete

183

48

NIC

United States
Australia
Australia
Canada
USA

Athlete
Athlete
Athlete
Athlete
Athlete

20
36
25
10
72

20
42*
42*
11
66

NIC
NIC
NIC
NIC
NIC

USA

Athlete

165

166

NIC & PIB 17.46

US

Athlete

36

36

NIC & PIB

19.5

13

31

USA

Athlete

166

164

NIC & PIB 17.47

11

16.3

US
USA
France
Australia
USA
Australia

Athlete
GMR
GMR
GMR
GMR
GMR

105
11
89
79
15
16

105
12
70
86
15
16

NIC
NIC
OI
OI
NIC
NIC

10
14.09

100
27
22.5
24
13.3
37.5

Switzerland

GMR

49

49

USA
Canada

GMR
GMR

30
15

30
15

Register-Mihalik (2013)
Sasaki (2014)
Macciocchi (1996)
Terry (2012)
Collie (2006)b
Collie (2006)a
Gosselin (2007)
Schatz (2005)
Nelson (2016)

Guskiewicz (2001)

Chin (2016)
Forbes (2016)
Fischer (2016)
Nash (2014)
Shores (2008)
Mayer (2015)
Barwood (2013)
Dall'Acqua (2017)
Mayer (2014)
Saluja (2015)

NIC & PIB 15.6
NIC
17.52
NIC
NIC
24.2
NIC
15.5

Mean
Education

NIC & PIB 18.59
NIC
21.68

0.4

13.89

0

Injury Parameters
%
%
%
Previous
LOC PTA
MTBI
40
15.6 16.48

Mixed
Mixed
0
Mixed
Mixed

No
No
Yes
Yes
No

53

Mixed

No

0

53

Mixed

No

34.85
38

38.23

Mixed
Mixed

No
No

0

No

0
Mixed
Mixed
0
Mixed

No
No
No
No
Yes

Mixed

Yes

Mixed

No

Mixed

No

Mixed
Mixed
Mixed
Mixed
0
0

No
No
No
Yes
No
No

0

0

Yes

20

Mixed
Mixed

Yes
No

0
0
16.66

0
20.3
23.3
22.3
24.3
16.5

14.3

14.7
20.8

Psych
PVTs TSI (days)
Comorbidity

0
0
0
30
10.4

4.8
100

100

22
19.4
32
20
99

44.4
36.1
36
40

16.4

15.9
33
35.4
31.5
13.47
38.25

11.4
6.87
12.875

NIC

34.9

12.6

63.2

NIC
NIC

27.83
15

13

46.67
53.3

19

36

54.5

0

66.6
87.5

31

37.5

6.3
0.0104
4.5
1.935
35.66
1
7
1
7
2.36
95
1
5
10
588
3.5
2.2
132
3
0.7954
8
15
45
1
5
1
8
15
45
813
0.246
360
0.261
15.33
348.75
5.28
360
15
39.3

d
0.924
1.029
0.394
0.371
0.683
1.035
-0.054
1.137
0.911
0.409
0.009
0.479
0.382
0.467
0.363
-0.018
0.169
0.413
1.108
0.527
0.169
0.073
0.035
0.542
0.345
0.267
0.011
-0.005
-0.08
0.016
1.061
-0.185
1.089
0.439
-0.298
0.358
0.183
0.246
0.456
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Table 5 continued.
Characteristics of Included Studies
Sample Information
Sample
Raz (2011)
Macciocchi (2013)
Xiong (2014)
Studer (2015)
Sheedy (2009)
Goldstein (2001)
Cicerone (1997)
De Monte (2005)
Borgaro (2003)
Meyers (2004)
Hess (2003)
Shee (2016)
Chen (2012)
Harman-Smith (2013)
Levin (1987)
McNally (2013)d
McNally (2013)c
Subotic (2017)b
Subotic (2017)a
Bohen (1995)b
Bohen (1995)a
Sroufe (2010)
Lange (2015)b
Lange (2015)a
Acreman (2014)
Bergloff (1995)
Sheedy (2006)
Schmidt (2017)
Bodzy (2011)
Mayer (2011)
De Monte (2005)h
De Monte (2005)i
Padre (2009)
Diwakar (2015)
Van Beek (2015)

Country

Demographic Information

Population n MTBI n Control

Control
Group

Age

Mean
Education

%
Female

USA
USA
China
Germany
Australia
USA
USA
Australia
USA
USA
USA
USA
Taiwan
Australia

GMR
GMR
GMR
GMR
GMR
GMR
GMR
GMR
GMR
GMR
GMR
GMR
GMR
GMR

28
53
25
36
100
18
50
112
14
57
33
91
20
84

18
64
25
27
100
14
40
32
14
32
33
86
18
95

NIC
OI
NIC
OI
OI
NIC
NIC
OI
NIC
CP
OI
NIC
NIC
OI

35.6
26.91
32.5
11
33.64
62.3
34.6
25.35
46.1
36.93
37.2
33.7
36.6
34.8

USA

GMR

57

56

NIC

23.22

USA
USA
Canada
Canada
Netherlands
Netherlands

GMR
GMR
GMR
GMR
GMR
GMR

112
74
17
28
11
11

44.5*
44.5*
9*
9*
5.5*
5.5*

OI
OI
NIC
NIC
NIC
NIC

11.83
12.15
42.7
46.1
27.4
27.2

USA

GMR

28

45

OI

13.5

Canada
Canada
Canada
USA
Australia
USA
USA
USA
Australia
Australia

GMR
GMR
GMR
GMR
GMR
GMR
GMR
GMR
GMR
GMR

52
20
41
15
100
14
62
27
50
14

18*
18*
39
15
100
14
82
26
18
8

OI
OI
CP
NIC
OI
NIC
NIC
NIC
OI
OI

34.1
34.1
38.63
28
33.62
20.2
10.83
27.15
26.86
24.42

15.3
14.4
13.8
13.23
13.22
12.9
13.22
12.79
12.47

46.66
57.7
100
0

Canada

GMR

37

79

NIC

26.7

13.14

35.14

USA

GMR

25

25

NIC

32.7

14.7

16

Belgium

GMR

20

20

NIC

10.8

Injury Parameters
%
%
%
Previous
LOC PTA
MTBI

Psych
PVTs TSI (days)
Comorbidity

13.19

32
11.3
36
54.3
22

14.8
12.53
11.8
12.63
11
14.3
15
13.3

20.5
30
24.56
21
938.5
50
54

12.38

39

14.9
16.4
5.1
4.6

33
23
53
82
45.45
45.45

47
50

43

19

25

29

0

Yes

21.2
45
31.7
53.33
31

0
0

94.2
90

100
100

44.8

72.4

0

0

0

Mixed
Mixed
Mixed
Mixed
Mixed
Mixed
0
0
0
0

Yes
Yes
Yes
No
No
No
No
Yes
No
No

81.08

100

0

No

64

96

0

Yes

0

No

11.89
12.84

35

0
0
31.4

36.1

52.8

59

0

0
100

0

0
Mixed
Mixed
Mixed
Mixed
Mixed
Mixed
0
Mixed
Mixed
Mixed
Mixed
0
0

No
No
No
No
No
No
Yes
No
No
Yes
no
No
No
Yes

0

No

Mixed
Mixed
Mixed
Mixed
0
0

No
No
No
No
No
No

558.9
48
32.07
120
0.579
24.99
396
0.353
15.6
227.7
33.4
39.5
16.9
168.7
7
30
10.5
10.5
8.5
8.5
687
678
1
7
31.5
46.8
46.7
30
358.5
0.725
11
2
11.32
0.3246
0.3342
4.4
93
954
12.85
201

d
0.895
0.163
0.538
-0.05
0.539
0.365
0.605
0.334
1.207
0.576
0.655
0.208
0.211
0.191
0.979
0.405
-0.061
-0.145
1.059
1.086
-0.434
0.456
-0.012
0.052
0.212
0.091
0.048
-0.818
0.612
0.497
0.22
0.167
0.166
1.039
0.569
0.389
0.25
0.507
0.995
0.346
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Table 5 continued.
Characteristics of Included Studies
Sample Information
Sample
Keightley (2014)
Gulbrandsen (1984)
McKinlay (2002)
Leh (2017)

Country

Demographic Information

Population n MTBI n Control

Control
Group

Age

Mean
%
Education Female

Canada
Norway
New Zealand
Canada

GMR
GMR
GMR
GMR

15
56
86
15

15
56
613
13

NIC
NIC
NIC
NIC

14.47
11.33
4.87
30.7

12.4

53.33
32.14
42.47
60

Studer (2014)h

Switzerland

GMR

23

13

OI

11.05

6

100

27.5

35

Studer (2014)i

Switzerland

GMR

17

25

OI

11.05

6

0

27.5

35

Belguim

GMR

20

20

NIC

10.8

35

0

USA

Litigant

120

130

TC

28

12.4

Hattori (2009)
Lange (2014)
McAuley (2014)
Hattori (2009)
Leininger (1990)d
Leininger (1990)c
Curtis (2012)
Richards (2000)g
Richards (2000)j
Zakzanis (2011)
Mathias (2004)
Raskin (1997)n
Raskin (1997)o

USA
Canada
USA
USA
USA
USA
USA
Canada
Canada
Canada
Australia
USA
USA

Litigant
Litigant
Litigant
Litigant
Litigant
Litigant
Litigant
Litigant
Litigant
Litigant
Litigant
Litigant
Litigant

15
43
73
15
22
31
71
20
20
20
40
10
10

15
36
65
15
11.5*
11.5*
133
20
20
54
40
10
10

NIC
OI
OI
NIC
NIC
NIC
CP
NIC
NIC
NIC
NIC
TC
NIC

45
30.4
19.1
45
30.7
32.9
42.5
26.85
69.1
39
32.4
41.8
40.4

16
14.6
10.5
16
13.5
13.7
12.6
14.1
12.7
13.1
12.4
14.2
13.2

80
23.3
27.4
80
55
60
36.6
50
50
50
20
100
100

Ponsford (2011)

Australia

Litigant

90

80

OI

34.98

13.58

26

USA

Litigant

94

80

OI

29.11

39.4

Veteran
Veteran
Veteran
Veteran
Veteran
Veteran

440
197
305
30
56
63

88
200*
200*
15
773
554

NIC
NIC
NIC
NIC
NIC
NIC

28.8
25.9
26
30.7
26.9
26.65

0
6.23
7.61
13
0
0

Van Beer (2015)
Dikmen (2017)

Nelson (2017)

Haran (2016)
United States
Roebuck-Spencer (2012)b
USA
Roebuck-Spencer (2012)a
USA
Sorg (2014)
USA
Ivins (2015)
USA
McCrea (2014)
USA

0

Injury Parameters
%
%
%
Previous
LOC PTA
MTBI
20
0
0
0
0
0

13.3

0

0
0

93
78.1
0
58.4
60.3
77
55

0
0
Mixed
0

No
No
No
No

50

0

No

50

0

No

0

No

Mixed

No

33.333

0
Mixed
Mixed
Mixed
Mixed
Mixed
Mixed
0
0
0
Mixed
1
Mixed

No
Yes
No
No
No
No
Yes
No
No
Yes
Yes
No
No

96.7

Mixed

No

Mixed

Yes

Mixed
Mixed
Mixed
0
Mixed
Mixed

No
No
No
Yes
Yes
No

0

80

92.5
35.1

73

20.7
31.5
60
53.5
54.7

Psych
PVTs TSI (days)
Comorbidity

4.6
9.1
0
62.5
29.4

41.13
180
30
126
30
120
30
120
12.85
30
360
858
46.1
2.5208
858
183
252
780
720
954
748.3
26.3
427.2
746.7
7
90
1.62
14.6
43.8
3.06
402
404
1080
23
1

d
0.422
0.283
0.18
0.435
-0.017
0.166
-0.109
-0.041
0.417
0.017
-0.073
0.574
0.091
+

2.18
0.574
0.467
0.558
0.03
0.986
1.11
1.156
0.464
0.293
0.843
0.259
0.139
0.027
-0.192
0.103
0.55
4.203+
11.482+
0.353
0.666
1.613
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Notes: LOC = Loss of Consciousness; PTA = Post-traumatic Amnesia; PVTs = Performance Validity Tests; TSI = Time Since Injury
in days; NIC = Non-Injured Control; NIC & PIB = Non-Injured Control and Pre-Injury Baseline; TC = Trauma Control; OI =
Orthopedic Injury; CP = Chronic Pain; GMR = General Medical Referral; *=outlying effect size prior to trimming; + = control group
was split in half and distributed among both independent samples
a = independent sample with PCS; b = independent sample without PCS; c = independent sample with LOC; d = independent sample
with no LOC; e = independent sample with children; f = independent sample of high school/college students; g = independent sample
of adults; h = independent sample of females; i = independent sample of males; j = independent sample of older adults; l =
independent sample of high school students; m – independent sample of college students; n = independent sample of individuals who
sustained traumas; o = independent sample of individuals who did not sustain trauma
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Publication Bias. Given the lack of independence in studies with multiple
outcome measures (i.e., memory, processing speed, executive functioning), all analyses
assessing publication bias were conducted using the overall cognitive dysfunction
outcome measure. A Fail-Safe N analysis across all time points revealed that 5,254
missing studies with a null effect are needed to bring the observed effect size to a nonsignificant value (i.e., p < .05). Visual inspection of a funnel plot reveals a general
symmetry of observed effects across the overall observed effect (Figure 3), suggesting no
evidence of publication bias. Similarly, a formal test of asymmetry, Egger’s regression
intercept found a non-significant intercept (𝛽0 = 0.556, t(150) = 1.17, p = 0.24), which
suggests no evidence of publication bias.
Figure 3.
Funnel Plot of Overall Effect Size
Funnel Plot of Standard Error by Std diff in means
0.0

Standard Error

0.2

0.4

0.6

0.8
-3

-2

-1

0

1

2

3

Std diff in means

Aim 1: Pair-Wise Meta-Analytic Findings
Cognitive Functioning Over Time. Table 6 shows the results of the randomeffects meta-analysis, which displays the observed effects size for each cognitive domain
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stratified by time. This analysis does not control for potential effect modifiers (i.e.,
population, psychological comorbidity, PVTs). For this analysis, the time points are
assumed to be independent of one another. While each study only contributes one study
per time strata, there is an inherent violation of independence and perfect correlation (r =
1.00) is assumed when comparing the effects between time strata (e.g., 24 hours vs > 90
days). As such, the standard errors within a time point stratum may be erroneously small,
resulting in an increase in potential Type I errors when estimating the effect size within
each time strata. Conversely, assuming a perfect correlation across time points results in
an inflation of the standard error when comparing between-time strata, resulting in an
increase in potential Type II errors.
In general, medium to large effect sizes were evident in acute stages post-MTBI,
which decreased over time. Contrary to expectation, effect sizes tended to increase again
after 90 days post-MTBI. Consistent with Hypothesis 1, medium overall effect sizes were
evident in the acute periods post-MTBI (≤24 hours, 1-8 days). In contrast to expectation,
the overall effect size remained significant, even after 3 months. More detailed analyses
across each cognitive domain are outlined below.
Overall Cognitive Dysfunction. The analogue-to-ANOVA failed to reach
significance (Q Between(4) = 8.907, p = .063) suggesting there were no differences in
observed effect sizes over time. Consistent with previous meta-analyses, a medium-tolarge effect size (d = .641) was observed when assessing overall cognitive functioning
during the first 24 hours after sustaining an MTBI. A medium-small effect size is
observed 1-8 days post-MTBI (d = .415) and small, but significant effect sizes is
observed until 90 days post-MTBI (d range .271-.240). Contrary to the previous research,
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Table 6
Cognitive Dysfunction Post-MTBI Stratified by Time

k
Orientation
General Ability/IQ
Language/Achievement
Attn/Working Memory
Processing Speed
Executive Function
Immediate Memory
Delayed Memory
Visuospatial Skills
Fine Motor Mvmt
Overall

11
5
1
12
14
8
17
17

≤ 24 Hours
d
95% CI

Q

0.887* 0.617-1.158 49.989*
1.296* 0.759-1.833 161.07*
0.201 -0.311-0.712 0.00
0.52* 0.33-0.711 30.3*
0.605* 0.38-0.829 29.87*
0.259 -0.015-0.533 15.1*
0.628* 0.405-0.851 128.85*
0.723* 0.504-0.942 137.94*

2 0.786 0.291-1.281 0.64
22 0.641* 0.432-0.85 116.55*

1-8 Days
95% CI

k

d

2
7
1
18
30
16
14
27
4
2
36

0.252
0.232
-1.071*
0.348*
0.472*
0.254*
0.334*
0.425*
0.379
0.459
0.415*

-0.326-0.83
-0.239-0.703
-1.69 - -0.452
0.188-0.508
0.319-0.625
0.073-0.434
0.085-0.584
0.25-0.6
-0.113-0.87
0.056-0.862
0.251-0.578

Q

k

1.55
9.98
0.00
29.8*
121.96*
30.54*
75.89*
127.45*
18.49*
1.23
139.592*

1
13
6
18
18
16
8
15
6
3
29

9-30 Days
d
95% CI
0.996
0.167
0.203
0.191*
0.203*
0.198
0.275
0.367*
0.238
0.078
0.271*

-0.09-2.082
-0.185-0.52
-0.036-0.442
0.016-0.366
0-0.406
-0.005-0.401
-0.061-0.61
0.12-0.615
-0.159-0.635
-0.185-0.341
0.083-0.459

Q

k

0.00
25.683*
7.20
44.76*
69.93*
68.56*
5.52
36.2*
15.73*
4.33
90.407*

3
12
4
13
13
13
10
15
8
3
20

Note . IQ = Intelligence Quotient; Attn = Attention; Mvmt = Movement
Values that are bolded and have an * indicate values with p < .05; Significance levels were not futher stratified

Figure 4.
Overall Cognitive Dysfunction Over Time

31-89 Days
d
95% CI
0.143
0.28
0.121
0.054
0.26*
0.205
0.3
0.369*
0.312
0.446
0.24*

-0.395-0.68
-0.092-0.651
-0.192-0.435
-0.144-0.251
0.024-0.496
-0.02-0.431
-0.003-0.604
0.131-0.607
-0.032-0.655
0.073-0.819
0.015-0.464

Q

k

d

10.36*
25.68*
1.86
12.53
21.7*
23.69*
9.84
28.08*
31.78*
1.65
22.00

2
18
9
28
30
30
26
26
10
7
45

0.584
0.641*
0.249*
0.27*
0.274*
0.201*
0.274*
0.332*
0.345*
0.293
0.391*

≥ 90 Days
95% CI

Q

-0.15-1.319
0.00
0.327-0.956 23.17*
0.053-0.445 14.63
0.128-0.413 72.74*
0.112-0.436 89.93*
0.046-0.356 67.32*
0.076-0.472 45.22*
0.138-0.526 33.89
0.035-0.654 17.1*
0.108-0.478
5.66
0.235-0.546 337.426*

Q between
8.579
15.038*
16.188*
12.838*
10.667*
0.326
6.608
8.289
0.245
7.608
8.907
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the effect size increases from small to medium-small after 90 days (d = .391). This
finding likely reflects the fact that most of the studies with litigant and Veteran samples
were assessed at this time point (see Population analyses). Significant between-study
heterogeneity was observed for all time points except the 31-89 day time strata.
Orientation. A large effect size (d = .887) in orientation was observed in the first
24 hours post-MTBI. Effect sizes across the other time strata were non-significant, likely
due to the small number of studies. Nevertheless, observed effect sizes in these time
strata ranged from small to large (d range = .252-.996). The analogue-to-ANOVA failed
to reach significance (Q Between(4) = 8.579, p = .073), suggesting no significant
differences in observed effect sizes over time. Significant between-study heterogeneity
was evident in the ≤ 24 hour and 31-89 day time strata.
General Ability and Intelligence. There were significant differences in observed
effects across time points (Q Between(4) = 15.04, p = .005). A very large effect size was
observed in the first 24-hours post-MTBI. Small, non-significant effect sizes (d range
.280-.167) were observed in the 1-8 day, 9-30 day, and 31-89 day time strata, all of which
were significantly smaller than the effect size observed ≤ 24 hours post-MTBI (all p’s <
.05). Mirroring the results of analysis of overall cognitive dysfunction, a non-significant
increase in the effect size from small to medium-large was observed after 90 days (d =
.641; Z = 1.46, p = .15). The effect size observed after 90 days remained significantly
smaller than the initial effect size observed at 24 hours (Z = 2.060, p = .04). Significant
between-study heterogeneity was observed in all time strata except the 1-8 day time
strata.
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Language and Academic Achievement. The analogue-to-ANOVA was
significant (Q Between(4) = 16.188, p < .01) suggesting differences in observed effect
sizes over time. A small, non-significant effect size was observed in the first 24 hours,
post-MTBI (d = .201). After 1-8 days, the effect size significantly decreased from small
to a very large, negative effect size (d = -1.07; Z = 3.10, p < .001). Notably, this observed
effect was derived from a single study (Moser et al., 2005) and this effect size was
identified as an outlier and trimmed to its current value of -1.07; thus, this is unlikely to
be an accurate reflection of the true population effect size at this time point. Small, nonsignificant effect sizes were observed in the 9-30 day and 31-89 day time strata.
Mirroring the previous analyses, a non-significant increase in effect size (Z = .676, p =
.50) was observed after 90 days. After 90 days, a small, but significant effect size was
observed (d = .249), This effect size did not differ from the non-significant effect size
observed the initial 24 hours post-MTBI (Z = .17, p = .86). No significant between-study
heterogeneity was observed.
Attention and Working Memory. The analogue-to-ANOVA was significant (Q
Between(4) = 12.838, p = .012), suggesting differences in observed effect sizes across
time strata. A medium effect size was observed in the first 24 hours post-MTBI (d =
.520). A non-significant decrease to a medium-small effect size (d = .348) was observed
in the 1-8 day time strata. A small, but significant, effect size was observed after 9-30
days (d = .191) and a near-zero effect size was observed after 31-89 days (d = .054). Both
of these observed effect sizes were significantly smaller than the effect size observed in
the first 24 hours post-MTBI (all p’s < .05). A non-significant increase in observed effect
size was observed after 90 days (d = .270, Z = 1.74, p = .08). The small effect size
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observed after 90 days was significantly smaller than the medium effect size observed in
the first 24 hours post-MTBI (Z = 2.06, p = .04). Significant between-study heterogeneity
was observed in all time strata except the 31-89 day stratum.
Processing Speed. The analogue-to-ANOVA was significant (Q Between(4) =
10.667, p .031), suggesting differences in observed effect sizes across time. A mediumlarge effect size was observed in the first 24 hours post-MTBI (d = .605). A nonsignificant decrease to a medium effect size (d = .472) was observed after 1-8 days (Z =
.956, p = .33). A significant decrease to a small effect size was observed in the 9-30 day
time strata (d = .203; Z = 2.07, p = .0381). Small, but significant, effect sizes were
observed across the remaining time strata (d = .260 and .274). Significant between-study
heterogeneity was observed in all time points.
Executive Functioning. The analogue-to-ANOVA was not significant (Q
Between(4) = .326, p = .99), suggesting there were no differences in observed effect sizes
over time. In the first 24 hours post-MTBI, a small, non-significant effect size was
observed (d = .259). Small effect sizes were observed across the remaining time strata;
however, only the effect sizes from the 1-8 day stratum and > 90 day stratum reach
statistical significance (d = .245 and .201, respectively). Significant between-study
heterogeneity was observed in all time strata.
Immediate Memory. The analogue-to-ANOVA failed to reach statistical
significance (Q Between(4) = 6.61, p = .158). In the first 24 hours post-MTBI, a mediumlarge effect size was observed (d = .605). This was reduced to a medium-small effect size
after 1-8 days (d = .334). Non-significant, medium-small effect sizes were observed in
the 9-30 day and 31-89 day strata (d = .275 and .300, respectively). However, a medium-
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small effect size after 90 days did reach statistical significance (d = .274). Significant
between-study heterogeneity was observed in all time strata except the 9-30 day and 3189 day time strata.
Delayed Memory. The analogue-to-ANOVA failed to reach statistical
significance (Q Between (4) = 8.289, p = .082). In the first 24 hours post-MTBI a
medium-large effect size was observed (d = .723). Significant, medium-large effect sizes
were observed across the remaining time strata (d range = .332-.425). Significant
between-study heterogeneity was evident in all strata except the > 90 day time strata.
Visuospatial Skills. The analogue-to-ANOVA failed to reach statistical
significance (Q Between (4) = .245, p = .970), suggesting no differences in observed
effect sizes across time points. A non-significant, medium-small effect size (d = .375)
was observed 1-8 days post-MTBI. Non-significant, small (d = .238) and medium-small
(d = .312) were observed in the 9-30 and 31-89 day time strata. After 90 days, a
significant, medium-small effect size was observed (d = .345). Between-study
heterogeneity was evident across all time strata.
Fine Motor Movement. The analogue-to-ANOVA failed to reach statistical
significance (Q Between(4) = 7.608, p = .107). A medium-large effect size was observed
in the first 24 hours post-MTBI; however, this effect failed to reach significance, likely
due to the small number of included studies. Similarly, the observed effect sizes for the
remaining time strata failed to reach statistical significance (d range = .078 - .459).
Population. Random effects Analogue-to-ANOVA was conducted to examine
differences in overall cognitive functioning across different populations (See Table 7). In
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Table 7
Overall Cognitive Dysfunction Post-MTBI Stratified by Time and Population
≤ 24 Hours
k

d

95% CI

1-8 Days
2

I

Q

k

d

95% CI

9-30 Days

Athletes

13 0.575* .357-.792 49.64*

75.82

27 0.366* .192-.540 65.76*

GMR

8 0.594* .305-.883 18.96*

63.08

5

Litigants
Veterans

0.357 -0.038-0.752

Q Between

-

-

1

0.55

-0.231-1.33

8.022*

k

d

95% CI

Athlete

9-30 Days
GMR

Litigant

d

95% CI

2

I

Q

I

13 0.125 -0.099-0.35

3.02

0.00
24.82

d

95% CI

-.060-.216

5.22 23.43

18 0.247*

.033-.461

63.21

9 .283*

.110-.456

4.92

0

18 0.262* 0.071-0.453

22.61

3 0.093

-.358-.544

4.39 54.45

2 0.097

-.230-.424

0

0

11 0.437* 0.193-0.68

29.81* 66.46

3 1.859* 1.425-2.292

35.1*

96.54

-

-

1 0.667 -.065-1.397

46.2*

1.724

31-89 Days
Veteran

≥90 Days

13.02 38.56

2

Q

k

9 0.078

2.632

1-8 Days

k

-.044-.585 25.74* 76.69

Figure 5.
Line Graph of Overall Cognitive Dysfunction Over Time by Population

≤ 24 hr

2

I

7 0.271

Notes. GMR = General Medical Referral
Values that are bolded and have an * indicate values with p < .05; Significance levels were not futher stratified

2.5
2.25
2
1.75
1.5
1.25
1
0.75
0.5
0.25
0
-0.25
-0.5

≥ 90 Days

31-89 Days
Q

60.46

3 0.777* .291-1.264 57.79*
1 1.613* .920-2.306

2

I

Q

3.426

51.292*

94.30
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contrast to the analyses reported above, there is no violation of independence as the
between-study analyses did not examine the effects of time, but rather population
membership.
In general, differences in sample population were found in the first 24-hours
post-MTBI and after 90 days, with samples that included Veterans having the largest
effect sizes. Samples that included athletes tended to have smaller effect sizes than
samples with general medical referrals (GMR) in the post-acute periods after the injury;
though these differences were not significant. Samples that included Veterans and
individuals involved in litigation continued to have medium to large effect sizes 90 days
after injury. Hypothesis 2A, that differences across populations would be evident, was
partially fulfilled. More detailed analyses regarding the overall effect of sustaining an
MTBI across various populations are provided below.
Population: 24 Hours or Less Post-Injury. Medium effect sizes were observed
for the athlete and GMR populations (d = .575 and .594, respectively). A very large effect
size was observed for Veteran populations (d = 1.613), though this estimate was derived
from a single study (French, McCrea, & Baggett, 2008). The analogue-to-ANOVA (Q
Between (2) = 8.022, p = .018) was significant suggesting differences in in effect sizes
across populations. The observed effect sizes for the GMR and athlete populations were
similar in magnitude (Z = .104, p = .92). However, the effect size for the Veteran
populations was significantly larger than the athlete and GRM populations (Z =2.80 and
2.66, all p’s < .05). Significant between-study heterogeneity was observed for the athlete
and GMR populations, with 63-75% of the variability unexplained. Given there was a
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single study across the Veteran population, metrics of between-study heterogeneity
cannot be calculated.
Population: 1-8 Days Post-Injury. The analogue-to-ANOVA failed to reach
significance (Q Between(3) = 2.63, p = .45), suggesting no differences in observed effect
sizes across populations. After 1-8 days, a medium-to-large effect size was observed for
studies that include individuals involved in litigation (d = .777). A significant mediumsmall effect size was observed for studies that included athletes (d = .366), and a nonsignificant medium-small effect size was observed for GMR populations (d = .357). A
medium, non-significant effect size was observed in the Veteran population, though only
one study contributed to this effect. Significant between-study heterogeneity was
observed the athlete and litigant populations, with 60-97% of the variability unexplained.
Population: 9-30 Days Post-Injury. The analogue-to-ANOVA failed to reach
significance (Q Between(3) = 2.632, p = .452), suggesting no differences in observed
effect sizes across populations 9-30 days post-MTBI. A small, significant effect size was
observed for the GMR population (d = .247), while studies that included athletes also had
a small effect that failed to reach significance (d = .271). A non-significant, mediumlarge effect size was observed in Veteran population (d = .667), though only a single
study contributed to this estimate. Finally, a near-zero effect size was observed for
studies that included individuals involved in litigation (d = .093). Significant betweenstudy heterogeneity was evident for studies involving athletes and GRM with 63-80% of
the variability left unexplained.
Population: 31-89 Days Post-Injury. The analogue-to-ANOVA failed to reach
significance (Q Between (2) = 3.426, p = 0.18), suggesting no differences in observed
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effect sizes across populations after 31-89 days post-MTBI. A near-zero effect size was
observed for studies involving athletes (d = .078) and individuals involved in litigation (d
= .097). A small, significant effect size was observed for studies involving GMR (d =
.283). Significant between study-heterogeneity was evident in studies involving athletes,
with 39% of the variance between studies left unexplained.
Population: 90 Days or More Post-Injury. The analogue-to-ANOVA was
significant (Q Between(3) = 51.292, p < .001), suggesting differences in observed effect
sizes across populations 90 days after injury. A near-zero effect size was observed for
studies that involved athletes (d = .125). A small, significant effect size was observed for
studies involving GRM (d = .262). A significant, medium-small effect size was observed
for studies that included individuals involved in litigation (d = .437). A very large effect
size was observed for studies involving Veterans (d = 1.895), which was significantly
larger than the observed effect sizes across the other populations (all p’s < .05).
Significant between-study heterogeneity was observed for studies involving litigants and
Veterans with 66-94% of the variability left unexplained.
Age. A random-effects meta-analysis was conducted to compare the overall
cognitive sequalae of sustaining an MTBI across different age groups and time points
(See Table 7). In general, consistent with Hypothesis 2B, there were no significant
differences in the observed effect sizes across different age groups. While the differences
were not significant, samples that included older adults tended to have the largest effect
sizes, followed by samples that included adults. Drawing conclusions about these
apparent differences were difficult given the small number of studies in certain groups.
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Table 8
Overall Cognitive Dysfunction Post-MTBI Stratified by Time and Age
≤ 24 Hours
k

d

95% CI

-0.01 -.908-.884

1-8 Days

9-30 Days

Q

I

2

k

d

95% CI

Q

I

2

k

-

-

1

0.052

-.872-.976

-

-

6 0.235

-.120-.590

d

95% CI

2

I

d

95% CI

2

0.297

-.179-.774
-.040-.256

1

HS/College

13 0.575* .326-.824 49.64*

75.82

26 0.454*

.243-.565 126.58* 80.25

10 0.214

-.068-.496 26.52* 66.07

10 0.108

Adults

8 0.839* .516-1.161 44.57*

84.30

9

.044-.609

12 0.299*

.041-.558

8 0.226* -.040-.256

1 0.365

-.636-1.37

11.86 32.53

Older Adults
Q Between

3.757

1.155

11.04 54.72

k

Children

.326*

50.35* 78.15
0.254

Notes. HS/College = High School and College
Values that are bolded and have an * indicate values with p < .05; Significance levels were not futher stratified

Figure 6.
Line Graph of Overall Cognitive Dysfunction Post-MTBI Over Time by Age
3
2.5
2
1.5
1
0.5
0
-0.5

≤ 24 hr

1-8 Days

9-30 Days

31-89 Days

≥90 Days

-1
-1.5
Children

HS/College

Adults

Older Adults

≥ 90 Days

31-89 Days
Q

2

Q

I

k
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4
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-

0.00
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Q

2

I

0.075 -0.648-0.798

2.07

0.00

11 0.119 -0.301-0.538

1.68

0.00

29 0.514* 0.254-0.774 302.53*
1

1.347

d

1.110 -0.311-2.531

4.201

90.74
-
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More detailed analyses regarding the age and the overall effects of sustaining an MTBI
are provided below.
Age: 24 Hours or Less Post-Injury. The analogue-to-ANOVA failed to reach
significance (Q Between(2) = 3.76, p = .15), suggesting no differences in overall effect
size across age groups in the first 24 hours post-MTBI. A near-zero effect size was
observed for the single study that included children (d = -.01). A significant, medium
effect size was observed for studies that included samples with high school and collegeaged students (d = .575). A significant, large effect size was observed with studies that
included adults. Significant between-study heterogeneity was observed for studies that
included high school and college-aged students as well as adults, with 76-84% of the
variability left unexplained.
Age: 1-8 Days Post-Injury. The analogue-to-ANOVA failed to reach significance
(Q Between(2) = 1.155, p = .561), suggesting no differences in overall effect size across
age groups in the 1-8 days post-MTBI. A near-zero effect size was observed for the
single study that included a sample of children (d = .052). Significant medium-small
effect sizes were observed for studies that included high school and college-aged students
(d = .454) and adults (d = .326). Significant between-study variability was observed for
studies that included high school and college-aged students, with 80% of the variability
left unexplained.
Age: 9-30 Days Post-Injury. The analogue-to-ANOVA failed to reach
significance (Q Between(3) = 0.25, p = .0.97), suggesting no differences in overall effect
size across age groups in the 9-30 days post-injury. Small, but non-significant effect sizes
were observed in studies that included children (d = .235) and high school and college-
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aged students (d = .214). A significant, medium-small effect size was observed in studies
that included adults (d = .299). And a non-significant, medium-small effect size was
observed in the single study that included older adults (d = .365). Significant betweenstudy heterogeneity in studies that included high school and college-aged students and
adults with 66-78% of variance in observed effect sizes within these groups left
unexplained.
Age: 31-89 Days Post-Injury. The analogue-to-ANOVA failed to reach
significance (Q Between(2) = 1.347, p = 0.51), suggesting no differences in overall effect
size across age groups in the 31-89 days post-injury. Small, non-significant effect sizes
were observed for samples that included children (d = .297) and high school and collegeaged students (d = .108). A small, but significant effect size was observed for studies that
included adults (d = .226). Between-study heterogeneity was not found across any of the
age groups.
Age: 90 Days or More Post-Injury. The analogue-to-ANOVA failed to reach
significance (Q Between(3) = 4.201, p = .241), suggesting no differences in overall effect
size across age groups 90 days or more post-MTBI. A near-zero effect size and small,
non-significant effect size was observed for studies that included children and highschool and college-aged students, respectively (d = .075 and .119). A medium effect size
was observed in samples that included adults (d = .514) and a very large, but nonsignificant effect size was observed in the single study that included older adults (d =
1.110). Significant between-study heterogeneity was evident in studies that included
adults, with 91% of the variance in observed effect sizes within these groups left
unexplained.
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Psychological Comorbidity. A random-effects analogue-to-ANOVA metaanalysis was conducted to examine the presence of psychological comorbidity on the
overall cognitive effects of sustaining an MTBI (see Table 9). Contrary to Hypothesis
2C, studies that included participants without comorbid mental health disorders did not
have smaller effect sizes than studies where mental health disorders may have been
present. These unexpected findings may be the result of the methodological decisions
regarding these data. That is, most studies were coded as “mixed” if the authors did not
specifically note that subjects were included/excluded for having mental health disorders
or if the composition fell anywhere between 1 and 99%. Additional details of the
analyses are presented below.
Psychological Comorbidity: 24 Hours or Less Post-Injury. The analogue-toANOVA failed to reach statistical significance (Q Between(1) = 1.239, p = .266),
suggesting there were no differences in the observed effect sizes between individuals
with and without psychological comorbidities in the first 24 hours post-MTBI. A
medium-small effect size was observed for studies where participants did not have
psychological comorbidities (d = .428) and a medium-large effect size was observed in
studies where psychological comorbidities were not excluded (d = .701). Significant
between-study heterogeneity was evident in studies where participants had psychological
comorbidities, with 84.34% of the variance in observed effect sizes within these groups
left unexplained.
Psychological Comorbidity: 1-8 Days Post-Injury. The analogue-to-ANOVA
failed to reach statistical significance (Q Between(1) = .362, p = .547), suggesting there
were no differences in the observed effect sizes between individuals with and without
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Table 9
Overall Cognitive Dysfunction Post-MTBI Stratified by Time and Psychological Comorbidity
≤ 24 Hours
k

d

95% CI

0.428* 0.002-0.854

1-8 Days
Q

0%

5

Mixed

17 0.701* 0.476-0.927 102.19*

I2

5.44 26.51
84.34

k

d

95% CI

9-30 Days
I2

Q

12 0.474* 0.215-0.734 22.28*

50.64

24 0.378* 0.202-0.554 116.24* 80.21

k

d

95% CI

≥ 90 Days

31-89 Days
I2

Q

k

d

95% CI

Q

I2

k

2.50

0.00

25 0.325* 0.033-0.618

19 0.167 -0.013-0.348 66.7*

16 0.104* 0.002-0.206

13.55

0.00

19 0.476* 0.156-0.796 305.61*

73.01

0.362

2.639

Notes. Values that are bolded and have an * indicate values with p < .05; Significance levels were not futher stratified

Figure 7.
Line Graph of Overall Cognitive Dysfunction Post-MTBI Over Time by Psychological Comorbidity
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psychological comorbidities 1-8 days post-MTBI. A medium-small effect size was
observed in studies where subjects had no psychological comorbidities (d = .474) and
studies where psychological comorbidities were not excluded (d = .378). For both groups,
significant between-study heterogeneity was evident, leaving 50-80% of the variability in
observed effect sizes within these groups left unexplained.
Psychological Comorbidity: 9-30 Days Post-Injury. The analogue-to-ANOVA
failed to reach statistical significance (Q Between(1) = 2.64, p = .100), suggesting there
were no differences in the observed effect sizes between individuals with and without
psychological comorbidities 9-30 days post-MTBI. While the effect sizes did not
significantly differ, there was an unexpected finding in which a significant small-medium
effect size was observed in studies where participants did not have psychological
comorbidities (d = .446); whereas, a small, non-significant effect size was observed for
studies where psychological comorbidity may have been evident (d = .167). Significant
between-study heterogeneity was evident for studies with mixed psychological
comorbidities, leaving 73% of the variability in observed effect sizes within this group
left unexplained.
Psychological Comorbidity: 31-89 Days Post-Injury. The analogue-to-ANOVA
did reach statistical significance (Q Between(1) = 5.954, p = .015), suggesting there were
differences in the observed effect sizes between individuals with and without
psychological comorbidities 31-89 days post-MTBI. Contrary to expectation, the samples
with no psychological comorbidities yielded a significantly larger effect size (d = .534)
than studies that included participants with psychological comorbidities (d =.104).
Significant between-study heterogeneity was not evident.
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Psychological Comorbidity: 90 Days or More Post-Injury. The analogue-toANOVA failed to reach statistical significance (Q Between(2) = .481, p = .786,
suggesting there were no differences in the observed effect sizes between individuals
with and without psychological comorbidities after 90 days post-MTBI. Medium-large
effect sizes were observed for studies where participants did not have psychological
comorbidities (d = .325) and studies where psychological comorbidities may have been
evident (d = .476). A small, non-significant effect size was observed for the single study
where all study participants had a comorbid mental health disorder (d = .293). Significant
between-study heterogeneity was evident for studies where psychological comorbidities
were not excluded, leaving 94% of the variability in observed effect sizes within this
group left unexplained.
Performance Validity Testing. A random-effects analogue-to-ANOVA metaanalysis was conducted to examine if the utilization of PVTs on the overall cognitive
effects of sustaining an MTBI (see Table 10). In general, the results showed no
significant differences in observed effect sizes between groups, contrary to Hypothesis
2D. While the differences did not reach statistical significance, studies that utilized PVTs
tended to have smaller effect sizes than studies that did not screen for suboptimal effort
with PVTs. Further details of the analyses are outlined below.
PVT: 24 Hours or Less Post-Injury. The analogue-to-ANOVA failed to reach
statistical significance (Q Between(1) = .347, p = .556, suggesting there were no
differences in the observed effect sizes between studies that did and did not utilize PVTs
in the first 24 hours post-MTBI. A medium effect size was observed for studies that
utilized PVTs (d = .510) and a medium-large effect size was observed for studies that did
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Table 10
Overall Cognitive Dysfunction Post-MTBI Stratified by Time and Performance Validity Testing
≤ 24 Hours
k

d

95% CI

1-8 Days
Q

2

I

k

d

9-30 Days

95% CI

Q

2

I

k

d

≥ 90 Days

31-89 Days

95% CI

Q

2

I

k

d

95% CI

Q

2

I

k

d

95% CI

Q

2

I

PVTs Not
Used

18 0.671* 0.441-0.902 100.27* 83.05

27 0.423* 0.252-0.593 113.12* 77.01

22 0.313* 0.123-0.504 55.77* 62.35

13 0.213* 0.076-0.349 20.79 42.29

37 0.382* 0.143-0.62

321.47* 88.80

PVTs Used

4

9 0.369* 0.086-0.653 25.95* 69.18

7 0.105 -0.198-0.409 34.58* 82.65

7 0.078 -0.115-0.271 0.34

8

14.41* 51.43

0.51* 0.028-0.993

Q Between

15.8*

81.01

0.347

0.1

1.299

Notes. PVT = Performance Validity Test
Values that are bolded and have an * indicate values with p < .05; Significance levels were not futher stratified

Figure 8.
Line Graph of Overall Cognitive Dysfunction Post-MTBI Over Time by Performance Validity Testing
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not utilize PVTs (d = .671). Significant between-study heterogeneity was evident, with
81-83% of the variability in observed effect sizes within each group left unexplained.
PVT: 1-8 Days Post-Injury. The analogue-to-ANOVA failed to reach statistical
significance (Q Between(1) = 0.100, p = .752), suggesting there were no differences in
the observed effect sizes between studies that did and did not utilize PVTs 1-8 days postMTBI. Small-medium effect sizes were observed for studies that did utilize PVTs (d =
.369) and for studies that did not utilize PVTs (d = .423). Significant between-study
heterogeneity was evident for both groups, leaving 68-77% of the variability in observed
effect sizes within each group left unexplained.
PVT: 9-30 Days Post-Injury. The analogue-to-ANOVA failed to reach statistical
significance (Q Between(1) = 1.30, p = 0.25), suggesting there were no differences in the
observed effect sizes between studies that did and did not utilize PVTs 9-30 days postMTBI. A small-medium effect size was observed for studies that did not utilize PVTs (d
= .313), whereas a small, non-significant effect size was observed for studies that utilized
PVTs (d = .105). Significant between-study heterogeneity was observed for both groups,
with 62-85% of the variability in observed effect sizes within each group left
unexplained.
PVT: 31-89 Days Post-Injury. The analogue-to-ANOVA failed to reach
statistical significance (Q Between(1) = 1.252, p = 0.263), suggesting there were no
differences in the observed effect sizes between studies that did and did not utilize PVTs
31-89 days post-MTBI. A small, significant effect size was observed for studies that did
not utilize PVTs (d = .213), whereas a non-significant, near-zero effect size was observed
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for studies that utilized PVTs (d = .078). Significant between-study heterogeneity was not
observed for either group.
PVT: 90 Days or More Post-Injury. The analogue-to-ANOVA failed to reach
statistical significance (Q Between(1) = .036, p = 0.85), suggesting there were no
differences in the observed effect sizes between studies that did and did not utilize PVTs
90 days after injury. A significant small-medium effect size was observed for studies that
did not utilize PVTs (d = .382), whereas a non-significant, small-medium effect size was
observed for studies that utilized PVTs (d = .434). This seemingly incongruous findings
that the larger effect size (PVTs used) failed to reach significance is likely an issue of
power as only 8 studies were included; whereas, 37 studies were included in the former
analysis. Significant between-study heterogeneity was not observed for both groups, with
51-89% of the variability in observed effect sizes within each group left unexplained.
Aim 1 Summary. When considering a heterogenous population and not
stratifying based on moderator variables, medium to large effect sizes were observed
across all cognitive domains in the acute stages of MTBI recovery. The effect size
decreased over the first 90 days. Contrary to expectation, the overall effect size appeared
to increase 90 days after injury. Subsequent analyses suggested this was likely driven by
the medium and very large effect sizes observed in studies during this time strata that
included individuals involved in litigation and Veterans, respectively. Across most time
strata, significant differences were not observed across age categories, studies that
utilized PVTs, and the composition of psychological comorbidities.
Hypothesis 1: Consistent with the previous literature, a medium overall effect is expected
in the acute period post-MTBI that will fail to reach significance after three months. This

80
hypothesis was partially supported. A medium overall effect was observed in the acute
stages, but it remained significant and increased after three months.
Hypothesis 2: It is expected that (a) effect sizes will differ across the different
“populations;” (b) effect sizes will not differ for the different age groups (c) effect sizes
will differ for individuals with psychological comorbidities (d) effect sizes will differ for
studies where effort testing is implemented. This hypothesis was partially upheld.
Between-group differences were observed across the different populations (a) and effect
sizes did not generally differ across age groups (b). Contrary to expectation, neither
psychological comorbidities (c) nor utilization of PVTs (d) resulted in differences in
observed effect sizes.
Hypothesis 3: Despite stratifying by these different effect modifiers and performing
multiple sub-group analyses, it is hypothesized that between-study heterogeneity will still
exist. This hypothesis was upheld. Across most comparisons, significant between-study
heterogeneity was evident, with I2 values as high as 94%. This suggests that stratifying by
an effect modifier across different time points is not sufficient to explain the variability
observed across the heterogenous population.
Aim 2: Meta-Regression Analyses
A random-effects meta-regression was conducted utilizing the furthest, most nonacute time point from each study, yielding 152 unique observations. Variables of interest
were first entered into the regression equation alone. Then, all significant variables were
entered into a single regression model (See Table 11; Etnier et al., 2006; Lee et al., 2012).
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Table 11
Meta-Regression Models Predicting Overall Neurocognitive Dysfunction After MTBI

Intercept
MTSI

B
0.395
0

Model 1
SE
t
0.044 9.06***
0
0.67

MTSI2
Age
PVT
Psych d
Population
GMR
Litigant
Veteran
k
Model F
Q
I2

B
0.393
0
0

Model 2
SE
t
0.062 6.30***
0
0.23
0

B
0.222

Model 3
SE
0.117

t
1.89

0.007

0.005

1.55

B
0.287

Model 4
SE
t
0.087 3.28***

B
0.062

Model 5
SE
0.046

t
0.183

0.47

0.052

9.01***

B
0.338

Model 6
SE
t
0.056 6.01***

B
0.437

Model 7
SE
0.244

t
1.79

0.06
0.143

0.101

1.42
F(3,148) = 9.76***
-0.012 0.085
-0.14
0.08
0.121
0.66
0.976
0.185
5.26

0.457
0.054 8.51***
F(3, 31) = 1.55
-0.414 0.247
-1.68
-0.303 0.251
-1.21
-0.626 0.403
-1.55

152
0.04
805.29***

152
0.22
803.19***

144
2.39
771.05***

152
2.01
803.23***

36
81.18***
24.1

152
9.76***
592.06***

36
21.46***
19.45

81.37%

81.45%

81.58%

81.33%

0.01%

81.28%

0.01%

0.30

0.99

R2 Analog
0.00
0.00
0.01
0.01
0.99
Notes. MTSI = Mean Time Since Injury; PVT = Performance Validity Testing; GMR = General Medical Referall; Psych d = The effect size of psychological distress
For PVT, the reference group is studies that utilized PVTs to screen for adequate effort; For Population, the reference group were studies that included Athletes
* = p < .05; ** = p < .01; *** = p < .001
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Figures 9-11
Scatterplots of Moderator Variables and Overall Cognitive Dysfunction
Meta-Regression of Mean Time Since Injury

Meta-Regression of Psych d
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Time Since Injury. The average amount of time that had passed since sustaining
an MTBI was entered into the regression equation as a continuous variable (Models1and
2). For the linear and non-linear models, the data were centered about the mean of 138.09
days. Contrary to expectation, neither the linear nor quadratic (i.e., Time2) equation for
mean time since injury was a significant predictor of the overall effect size (F(1,150) =
0.44, p = .51; F(1,150) = .022, p = .80). This unexpected finding is likely due to
increasing observed effect size after 90 days that was observed in analysis from Aim 1
(see Figure 4). For both models, nearly 0% of the between-study variability is explained
by the models (R2 Analog = 0.01 for both models). Given that time since injury is not a
significant predictor, it was not entered into subsequent regression analyses as proposed.
Age. The average age of the study samples was entered into the regression
equation as a continuous variable (Model 3). Consistent with Aim 1 analyses, this model
failed to reach statistical significance (F(1,142) = 2.39, p = .12) and again almost no
between-study variability explained by the model (R2 Analog = 0.01).
PVT. Performance validity testing was entered into the regression equation as a
categorical variable (Model 4). Studies that utilized performance validity testing to
exclude subjects with sub-optimal effort was used as the reference group. Consistent with
Aim 1 analyses, this model failed to reach statistical significance (F(1,150) = 2.01, p =
.16). Almost no between-study variance was explained by the model (R2 Analog = 0.01).
Psychological Functioning. A regression model using the composition of
psychological comorbidities as a categorical variable (0%, mixed, 100%) was first
entered into a meta-regression (not modelled). Consistent with the results of Aim 1, the
model failed to reach statistical significance (F(2,149) = .06, p = .9448).
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Next, the overall effect size of self-reported psychological functioning across all
domains (e.g., depression, anxiety, SUD) was entered into the regression equation as a
continuous variable (Model 5; Figure 5). There was one observed outlier that was > 3
standard deviations above the average of all effect sizes (d = 13.289). It was trimmed to
the next nearest group of effect sizes (d = 4.05). This model reached statistical
significance (F(1,34) = 81.18, p < .001). Based on this model, studies where the
differences in psychological functioning between the MTBI and control group was
almost non-existent (Psych d = 0.00) or the differences were small (Psych d = 0.20) a
small-medium effect size was predicted (d = .338 and .432, respectively). When the
effect size in self-reported psychological functioning between MTBI and control groups
is medium (Psych d = .50), then a medium effect size for cognitive functioning is
predicted (d = .573). When the differences in psychological wellbeing between the two
groups are large (Psych d = .80), the predicted effect size is medium-large (d = .714).
This model explains nearly 100% of the between-study variance (R2 Analog = .99).
While this model was extremely predictive, it is worth noting that this analysis included a
minority (k = 36) of the extracted studies.
Population. Population membership (i.e., Athlete, Veteran, GMR, Litigant), was
entered into the meta-regression as a categorical variable with studies that included
athletes as the reference group (Model 6; Figure 6). Athletes were selected as the
reference group based on a priori knowledge that athletes tend to recovery faster than
other populations after an MTBI (Belanger, Curtiss, et al., 2005; Belanger &
Vanderploeg, 2005). The overall model was significant (F(3,148) = 9.76. p < .001).
However, of the sub-groups, only studies that included Veterans was a significant
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predictor (t(148) = 5.26, p < .001), suggesting studies that included individuals involved
in litigation and GRM did not differ in observed effect size from athletes. Based on the
model, a small-medium overall cognitive effect size (d = .338) is observed for athletes
after sustaining an MTBI, whereas a very large effect size (d = 1.314) is observed for
Veterans who sustain an MTBI. This model explains 30% of the between-study variance
(R2 Analog = .30). A Time x Population interaction, however, failed to reach significance
(F(4, 147) = 1.19, p = 0.31).
Combined Models. A regression model with self-reported psychological
functioning (Psych d) and population membership were simultaneously entered into the
regression equation (Model 7). The overall model was significant (F(4,31) = 21.46, p <
.001) with nearly all of the between-study variance explained by the model (R2 Analog =
.99). The observed differences in psychological well-being between MTBI and control
groups (Psych d) was a significant predictor (t(31) = 8.51, p < .001), whereas population
membership was not a significant predictor (F(3,31) = 1.55, p .221). Similar to Model 5,
no differences in self-reported psychological functioning between the MTBI and control
groups (Psych d = 0.00) resulted in a small-medium overall cognitive effect size (d =
.437). Small (Psych d = .20) and medium (Psych d = .50) differences in psychological
functioning resulted in medium predicted effect size of overall cognitive functioning (d =
.528 and .665, respectively). Large differences in psychological well-being (Psych d =
.80) resulted in a large predicted effect size of overall cognitive functioning (d = .802).
Aim 2 Summary. A meta-regression to control for potential between-study
heterogeneity and quantify the effect of covariates on the overall neuropsychological
functioning post-MTBI was conducted. Surprisingly, the mean time since sustaining an
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MTBI was not a significant predictor; though this is likely due the increase in observed
effect sizes in the chronic periods (> 90 days) post-MTBI. Consistent with Aim 1
analyses, the age of the study sample and the utilization of PVTs were not significant
predictors. This differences in self-reported psychological functioning was a significant
predictor that explained most between-study variance. Population was a significant
predictor, with Veterans exhibiting larger effect sizes than athletes. However, population
was not a significant predictor when simultaneously entered into the regression equation
with psychological functioning. Overall, across heterogenous populations, the biggest
predictor of over overall cognitive functioning post-MTBI is psychological functioning.
Hypothesis 4: When entered into a meta-regression, time since injury, psychological
comorbidities, and PVT testing will be significant covariates. Effect sizes are expected to
decrease over time but increase in the presence of psychological comorbidities and
increase if PVT are not implemented. Whereas, population and age will not reach
significance. This hypothesis was partially upheld. Psychological functioning was a
significant predictor of overall cognitive effect size. As predicted, the average age of the
study sample was not a significant predictor, and population membership was not a
significant predictor after controlling for psychological functioning. However, mean time
since injury and utilization of PVTs were not significant predictors.
Supplemental Analyses
Meta-Regression for Acute-Only Studies. Given the unexpected finding that the
average time since injury was not a significant predictor over overall neurocognitive
dysfunction, exploratory analyses examined the predictive ability of the various effect
moderators in the acute (< 90 days) and post-acute (> 90 days) periods post-MTBI. Table

87
12 displays the results of the meta-regression models when considering studies in the
acute phase, only.
In contrast to the model that include all time points, mean time since injury is a
significant predictor in the meta-regression model for the acute-period, only (Model 1;
F(1, 106) = 7.49, p < .01). Based on this model, a medium effect size is observed in the
first 24 hours after injury (d = .490), which drops to a small effect size (d = .20) 41 days
post-MTBI.
When controlling for average time since injury, neither age (t(99) = 0.92, p > .05)
nor utilization of PVTs (t(106) = 1.69, p > .05) were significant predictors of overall
neurocognitive dysfunction in the first 90 days after sustaining an MTBI (Model 2,
Model 3). Consistent with the previous models, psychological functioning was a
significant predictor (t(19) = 7.96, p < .001) with nearly all between-study variability
accounted for by the model (R2 Analog = .99). When entered into the same model with
psychological functioning, mean time since injury fails to reach significance (Model 4;
t(19) = 0.42, p > .05)5. In contrast to the previous models, population membership was
not a significant predictor of overall neurocognitive dysfunction in the acute periods postMTBI (F(3, 102) = 1.93, p > .05). This may be due to the absence of studies with Veteran
populations, which was a significant predictor in the previous models.

5

It is worth noting that CMA 3 eliminates studies in a list-wise fashion. When considering the 20 studies
that included measures of psychological functioning, mean time since injury, by itself, was not a significant
predictor. Thus, the lack of significance of time to be a significant predictor is not necessarily an indication
that psychological functioning accounting for all of the variability, making time since injury nonsignificant.
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Table 12
Meta-Regression Models Predicting Overall Neurocognitive Dysfunction in the First 90 Days Post-MTBI

Intercept
MTSI
Age
PVT
Psych d
Population
GMR
Litigant
Veteran
k
Model F
Q
I2
2

B
0.49
-0.007

Model 1
SE
t
0.057 8.56***
0.003 -2.74**

B
0.378
-0.007
0.005

Model 2
SE
t
0.128 2.95**
0.003
-2.56*
0.005
0.92

B
0.365
-0.007
0.164

Model 3
SE
t
0.094 3.90***
0.003 -2.59**
0.097

B
0.027
0.001

Model 4
SE
0.091
0.003

t
0.3
0.42

0.512

0.064

7.96***

B
0.459
-0.007

Model 5
SE
t
0.067 6.90***
0.003 -2.61**

1.69
F(3,102) = 1.93
0.004
0.093
0.04
0.032
0.157
0.21
0.536
0.225
2.38

107
7.49**
410.2***

100
3.60*
384.16***

107
5.14**
409.63***

20
32.30***
17.72

107
3.40*
468.2***

74.40%

74.75%

77.36%

4.05%

77.36%

R Analog
0.14
0.15
0.13
0.99
0.22
Notes. MTSI = Mean Time Since Injury; PVT = Performance Validity Testing; GMR = General Medical Referall; Psych d = The effect size of psychological distress
For PVT, the reference group is studies that utilized PVTs to screen for adequate effort; For Population, the reference group were studies that included Athletes
* = p < .05; ** = p < .01; *** = p < .001

89
Figure 12
Scatterplots of Time Since Injury and Acute Overall Cognitive Dysfunction
Meta-Regression of Mean Time Since Injury (Days)
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Meta-Regression for Post-Acute Studies. Meta-regression models were
conducted when considering studies in the post-acute periods after sustaining an MTBI (>
90 days) and results are described below.
Mirroring the results from meta-regression model with all time points considered,
the models with time since injury (F(1, 44) = 1.02, p > .05), age (F(1, 43) = 1.81, p >
.05), or the utilization of PVTs (F(1, 44) = .04, p > .05) failed to reached statistical
significance. Similar to the earlier models, psychological functioning (F(1, 15) = 14.35, p
< .001) and population (F(3, 41) = 17.01, p < .001) were significant when these variables
were modeled alone. When both variables were entered into the same equation,
psychological functioning remained a significant predictor (t(15) = 3.81, p < .01),
whereas population membership failed to reach significance (F(3, 11) = 0.22, p > .05).
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Table 13
Meta-Regression Models Predicting Overall Neurocognitive Dysfunction 90 Days or More After MTBI

Intercept
MTSI
Age
PVT
Psych d
Population
GMR
Litigant
Veteran
k
Model F
Q
I2

B
0.234
0

Model 1
SE
0.191
0

t
1.22
1.01

B
0.024

Model 2
SE
0.298

t
0.08

0.013

1.35

0.185

B
0.434

Model 3
SE
0.248

t
1.75

-0.052

0.276

-0.19

B
0.087

Model 4
SE
0.074

t
1.17

0.372

0.098

3.79**

B
0.125

Model 5
SE
0.115

t
1.09

B
-0.18

Model 6
SE
0.471

t
-0.38

F(3,41) = 17.10***
0.137
0.15
0.91
0.311
0.169
1.84
1.733
0.249 6.96***

0.401
0.105 3.81**
F(3,11) = 0.22
0.266
0.47
0.57
0.272
0.467
0.58
0.059
0.549
0.11

45
1.02
335.48***

44
1.81
334.67***

45
0.04
335.88***

16
14.35**
19.08

45
17.10***
337.43***

16
3.75*
4.06

87.18%

87.45%

86.96%

21.38%

86.96%

0.01%

R2 Analog
0.01
0.01
0.01
0.99
0.80
Notes. MTSI = Mean Time Since Injury; PVT = Performance Validity Testing; GMR = General Medical Referall; Psych d = The effect size of psychological distress
For PVT, the reference group is studies that utilized PVTs to screen for adequate effort; For Population, the reference group were studies that included Athletes
* = p < .05; ** = p < .01; *** = p < .001

0.99
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Figure 13
Scatterplots of Time Since Injury and Post-Acute Overall Cognitive Dysfunction
Meta-Regression of Mean Time Since Injury (Days)
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Demographic Variables: Neither the meta-regression model with the mean
education level as a covariate(F(1,85) = 1.49, p = .225), percentage of females included
in the study sample (F(1,139) = .13, p = .717), nor the percent of ethnic minorities
included in the study sample (F(1,45) = .17, p = .069) were significant predictors of the
overall cognitive effect size post-MTBI.
Injury Parameters. Neither the meta-regression model with the percentage of
individual who reported LOC as a covariate (F(1,63) = .01, p = .928) nor the percentage
of individuals who reported PTA (F(1,45) = 1.75, p = .193) reached statistical
significance.
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Post-Concussive Symptomology. Seven studies had two independent sub-groups
comprised of individuals who were identified as having PCS and individuals who did not
have PCS. A large overall cognitive effect was observed in the sub-groups that included
individuals with PCS (d = .890 after average of 167.2 days) and a medium-large effect
was observed in the sub-group of participants who did not report PCS (d = .649 after
average of 168.4 days). However, the Analogue-to-ANOVA failed to reach significance
(Q Between(1) = .155, p = .693), suggesting no difference between the two groups.
In contrast, the effect size of self-reported PCS in the MTBI group relative to the
control group did significantly predict the overall neurocognitive effect size, with 76% of
the between-study variability accounted for by the covariate (See Table 14; Model 1).
However, this variable failed to reach significance once psychological functioning was
entered into the model simultaneously (Model 2).
Study Characteristics: Consistent with previous studies, there was a significant
difference in the observed effect sizes based on the control groups (Q Between(4) =
12.469, p = .014). Studies with non-injured control groups (d = .497) yielded an effect
size that was significantly larger than the effect size from all other control groups.
Control groups that consisted of individuals with orthopedic injuries yielded the next
largest effect size (d = .257), though the magnitude of this effect was not significantly
larger than any of the estimated effect sizes from other control groups. Studies that
utilized both non-injured controls and pre-injury baselines yielded the next highest effect
size (d = .216), though this failed to reach significance. The studies utilizing individuals
who sustained a trauma and individuals with chronic pain as their control group yielded
small, non-significant effect sizes (d = .038 and -0.063, respectively).
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Table 14
Meta-Regression Models Predicting Overall Neurocognitive Dysfunction After MTBI

Intercept
PCS d
Psych d
k
Model F
Q

Model 1
SE
t
0.047
0.508
0.043 9.03***

B
-0.031
0.393

B
0.013
-0.013
0.521

Model 2
SE
t
0.07
0.19
0.15
-0.08
0.162
3.21**

73
81.47***
113.81***

22
36.28***
10.32

37.62%

1.00%

2

I

2

R Analog
0.76
0.99
Notes. PCS = Post-Concussive Symptomology; Psych d = the effect size indicating
overall psychological functioning
* = p < .05; ** = p < .01; *** = p < .001

Table 15.
Overall Cognitive Dysfunction Post-MTBI Stratified by Control Group
k
Non-Injured Control
Non-Injury Control &
Pre-Injury Baseline
Orthopedic Injury
Chronic Pain
Trauma Control

d

95% CI

Q

I2

100

0.497*** .394-.599 499.055***

80.163

14
30
3
3

0.216
-.030-.463 36.788***
0.257** .080-.435 132.047***
-0.063 -.601-.475 18.237***
0.038
-.517-.592
0.702

64.663
78.038
89.033
0.01

Q Between
12.469*
Notes. * = p < .05; ** = p < .01; *** = p < .001
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Discussion
Mild traumatic brain injuries are a significant public health issue with respect to
pervasiveness (Cassidy et al., 2004) and economic burden (Ma et al., 2014; Max et al.,
1991). While it is well documented that many individuals recover from MTBI in as little
as nine days (e.g., McCrea, 2008), there are others who take up to 3 months for complete
neurocognitive recovery (e.g., Belanger, Curtiss, et al., 2005), and still others who fail to
return to their cognitive baseline years after their injury (Ruff, Camenzuli, & Mueller,
1996). Emerging research has identified a multitude of factors that might contribute to
protracted cognitive recovery from MTBI. However, due to differences in study
methodology, discrepant findings are pervasive in this broad literature, which creates
challenges for clinical researchers and healthcare professionals in management of MTBI.
Due to the number of potential factors that are likely to modify cognitive recovery,
empirical studies controlling for each of these factors would be difficult. Rather,
quantitative reviews have attempted to elucidate the effects of such variables (e.g.,
Belanger, Curtiss, et al., 2005; Belanger & Vanderploeg, 2005; Dougan et al., 2014).
These studies have been instrumental in furthering our understanding MTBI recovery
across different variables of interest. However, these meta-analytic studies examined
homogenous populations with restricted time frames, somewhat limiting their
generalizability.
The present study was an updated quantitative review of the MTBI literature that
simultaneously utilized traditional and contemporary meta-analytic techniques. This
study sought to determine how demographic factors (e.g., age), individual differences
(e.g., psychological functioning), and study designs (e.g., utilization of PVTs) might
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explain the apparent differences in neurocognitive recovery from MTBI across a
heterogenous population (e.g., athletes, Veterans, GMR, litigants). Capitalizing on the
recent explosion of literature, this study is the largest MTBI meta-analytic review to date.
Aim 1
The first aim of this study was to utilize traditional meta-analytic techniques to
determine if differences in observed effect sizes differed across various moderator
variables of interest. This was done by conducting multiple analyses via Analogue-toANOVA across each time point and effect modifier. Regarding overall neurocognitive
dysfunction, a medium-large effect size was observed in the initial 24 hours post-MTBI
that decreased to a small effect size over the first 90 days. Contrary to expectation,
however, the observed effect size appeared to increase from small to small-medium for
studies where assessments were conducted 90 days post-injury. This, however, was likely
driven by the larger proportion of studies with samples consisting of Veterans and
individuals involved in litigation in this time strata (k = 14 of 45). Effect sizes across
cognitive domains followed this general pattern with significant effect sizes for every
domain except orientation and fine motor movement after 90 days post-injury.
While this finding is surprising, it is not unique within the meta-analytic literature.
In Belanger, Curtiss, and colleagues’ (2005) meta-analysis, which included a
heterogenous clinical sample (individuals involved in litigation, prospectively recruited
patients, and patients selected due to continued symptom report), significant effect sizes
were observed, even in the post-acute (>90 day) periods across nearly all cognitive
domains (d range =.15 to .71). After multiple pair-wise analyses were conducted, the
authors determined that this effect was driven by an increase in observed effect sizes
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from individuals involved in litigation and patients recruited due to persistent
symptomology. Similarly, the overall effect sizes in the present study diminish with time
until the most post-acute time point (> 90 days) when there were a larger number of
studies that included individuals involved in litigation and Veterans.
Further moderator analyses in Aim 1 sought to examine differences in the
observed effect size of overall cognitive functioning across various effect modifiers.
Consistent with expectation, differences in observed effect sizes were evident across the
various populations of interest (i.e., athletes, Veterans, GRM, litigants), with studies that
included Veterans having a significantly larger effect sizes than studies that included
other populations. This is unsurprising given the exceedingly high rate of psychological
comorbidities that accompany Veterans post-deployment (Brenner et al., 2010), MTBI
might not be treated or detected in combat theater in favor of treating other injuries
(Belanger, Scott, et al., 2005), and the inherent medicolegal nature of obtaining medical
services for US Veterans.
Similar to Belanger, Curtiss, and colleagues’ (2005) study, the observed effect
size for studies with litigant populations increased in the post-acute (> 90 days) periods
after an MTBI. For reasons not entirely clear, the observed effect sizes in the present
study for this population in the post-acute period (> 90 days) is meaningfully smaller than
what was observed in Belanger’s study (d = .437 vs .777). This may due to
methodological differences in the authors using a fixed-effect analysis, which tends to
lead to higher effect sizes. More likely, this is due to the author’s decision to include
studies with complicated MTBI, which were excluded in the present study. Complicated
MTBI (i.e., evidence of skull fracture or brain hemorrhage), has a prolonged recovery
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course more like moderate TBI than MTBI. The smaller-than-expected effect size for
litigant samples may explain why the differences in effect size between litigant, GRM,
and athlete samples only trended towards significance. While the observed effect sizes
were not statistically smaller than litigant samples, the effect sizes for athlete samples
failed to reach significance after 8 days, which is consistent with the well-established
empirical literature (Belanger & Vanderploeg, 2005; Dougan et al., 2014; McCrea, 2008).
There is an increased recognition of the importance of administering PVTs during
clinical evaluations to detect suboptimal effort, which may confound results (Chafetz et
al., 2015). While studies that screened for invalid performance yielded smaller effect
sizes than studies that did not utilize PVTs, unexpectedly, these differences failed to
reach statistical significance at any timepoint. However, a similar pattern was found in
Belanger and Curtis’ (2005) analysis. For studies that involved litigant samples, they
found that the studies that screened for insufficient effort had a smaller observed effect
size (d = .50) than studies that did not utilize PVTs (d = .66), though this difference failed
to reach significance. Most striking is the overwhelming majority of studies (77%) that
reported no utilization of PVTs to screen for poor effort despite multiple professional
organizations imploring their utilization in clinical work and research (e.g., Chafetz et al.,
2015).
It is clear that most of the MTBI research included in these analyses focused on
adolescents and adults, which is problematic given that that children aged 0-4 years and
adults aged 75 are particularly prone to head injuries (Faul et al., 2010). Given the
discrepancy in empirical findings (e.g., Anderson et al., 2001; Grubenhoff et al., 2010;
Ponsford et al., 1999), it was important to evaluate age as a potential effect modifier ,
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Consistent with our hypotheses, age was not a significant predictor of neurocognitive
dysfunction post-MTBI. Notably, however, there was a much smaller percentage of
studies in the present study that included pediatric and geriatric populations. Thus, it is
difficult to make definitive conclusions regarding the effect of age from the present
analysis.
Unexpectedly, studies that excluded individuals with psychological or psychiatric
comorbidities did not yield higher effect sizes than studies where comorbidities were
excluded or presumed to exist. This finding is inconsistent with the rapidly emerging
literature that psychological functioning largely predicts MTBI outcomes (e.g., Combs et
al., 2015; Nelson et al., 2012; Verfaellie et al., 2014). This unexpected finding may be the
result of the lack of nuance from this categorical variable and the assumptions associated
with coding this variable. That is, most of the included studies were coded as “mixed.”
Studies were conservatively coded as having a mixed composition if any study
participant was reported to have a mental health disorder. Thus, there is incredible
variability in this outcome as studies could be coded as “mixed” if 1 to 99% of their study
participants were reported to have a comorbid mental health disorder. Additionally,
studies were coded as mixed if the authors did not report specific inclusion/exclusion
criteria associated psychological comorbidities. Thus, studies could have been incorrectly
coded if the authors did not formally measure psychological outcomes. Altogether, this
unexpected finding may be a result of methodological decisions associated with
developing a categorical coding of this variable, which may not be particularly
meaningful.
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Notably, limitations associated with methodological approaches utilized in Aim 1
are consistent with most prior MTBI meta-analyses conducted. Analogue-to-ANOVA
analyses require categorical data, restricting the variability of the effect modifiers. This
type of analysis also requires a separate analysis for each covariate and time point of
interest. Altogether, 20 separate analyses were needed to examine the impact of the
various effect modifiers on MTBI recovery over time, likely resulting in Type I errors.
Additionally, there is an inherent reduction in power as included studies are split among
the various analyses (largest k = 45). Consistent with nearly every previous MTBI metaanalysis, significant between-study heterogeneity (Cochran’s Q) was evident after most
analyses, leaving a significant majority of the variability left unexplained (I2) (Belanger,
Curtiss, et al., 2005; Belanger & Vanderploeg, 2005; Frencham et al., 2005; Rohling et
al., 2011).
Aim 2
The second aim of this study was to utilize meta-regressive techniques to quantify
the relative effect in overall neurocognitive functioning post-MTBI for each covariate,
and more fully account for the between-study heterogeneity evident in the literature and
replicated in Aim 1. Unlike the pairwise analyses from Aim 1, meta-regression analyses
can quantify the relative effect of each covariate on neurocognitive recovery with much
fewer analyses. Furthermore, the covariates can be examined continuously, rather than
categorically, maintaining important variability.
When considering all studies with time of assessment ranging from immediately
post-injury to three years, average time since injury did not predict overall neurocognitive
dysfunction. This held true when considering linear and non-linear equations. Again, this
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surprising finding was likely due to the comparatively large effect sizes for studies that
included individuals involved in litigation and Veterans. To further explore this issue,
supplemental analyses revealed that the average time that had elapsed since sustaining an
MTBI was a significant predictor only when examining the first 90 days after injury. This
variable, however, failed to be predictive when examining studies in the post-acute (>90
days) period. Taken together, this seems to suggest that in the post-acute periods after an
MTBI, when symptoms are not typically present, the amount of time that has passed
since the injury is no longer important in predicting overall cognitive functioning. Rather,
other key variables are likely to account for any residual differences between MTBI
populations and controls.
Given the consistent findings demonstrating a deleterious effect of psychological
distress and MTBI recovery (e.g., Combs et al., 2015; Nelson et al., 2012; Verfaellie et
al., 2014) it was important to evaluate emotional well-being in more systematic and
objective manner than in Aim 1. Uniquely, this is the first meta-analysis to systematically
examine psychological functioning after sustaining an MTBI. Analyses revealed that
psychological functioning was a significant predictor of neurocognitive dysfunction,
accounting for nearly 100% of the between-study variability despite only including 36
studies ranging from 2 to 954 days post-MTBI. While population membership was a
significant predictor, accounting for 30% of the between-study variability when
considered alone, this variable failed to reach significance when entered to the regression
equation simultaneously with psychological functioning.
The effect of psychological functioning seems to be primarily driven by studies
including individuals who have depression and/or PTSD (see Table 16). This is generally
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consistent with emerging MTBI research (e.g., Combs et al., 2015; Nelson et al., 2012;
Verfaellie et al., 2014) For example, Nelson and colleagues (2012) found that 3.5 years
post-injury, Veterans who sustained an MTBI did not differ in overall neurocognitive
dysfunction compared to controls; whereas, Veterans with MTBI and a comorbid Axis I
disorder performed much worse than controls, but did perform similar to Veterans with
no head injury and a comorbid mental health disorder. Similarly, other research has found
that cognitive and psychological functioning predicted functional outcomes 10 years after
sustaining an MTBI (Ponsford, Draper, & SchÖNberger, 2008). The importance of
psychological functioning in predicting cognitive functioning post-MTBI is also
consistent with research that demonstrates reliable decrements in neuropsychological test
performance for individuals with mental health disorders in the absence of head injuries.
For example, it is well-established that depression in older adults is a risk factor for
cognitive impairment (e.g., Dotson, Resnick, & Zonderman, 2008a). In addition, metaanalyses have found consistent neurocognitive decrements across the lifespan for
individuals with depression (Snyder, 2013) and PTSD (Johnsen & Asbjørnsen, 2008).
What remains unclear is if poor psychological functioning fully explains persistent
neurocognitive dysfunction in those with protracted recovery, or if continued dysfunction
may be attributed to the actual head trauma sustained during MTBI (e.g., neurometabolic
deficiencies, diffuse axonal injuries).
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Table 16.
Effect Sizes of Various Psychological Constructs
Internalizing Externalizing Overall
Construct Depression Anxiety PTSD SUD Somatiziation Behavior
Behavior Psych Fx
k
24
14
6
3
2
12
15
36
d
0.908
0.387 1.926 0.236
0.385
0.230
0.145
0.546
Notes. PTSD = Post-Traumatic Stress Disorder; SUD = Substance Use Disorder;
Psych Fx = Psychological Functioning

While the importance of psychological well-being in predicting cognitive
functioning post-MTBI is consistent with the existent literature, this finding differs from
the pair-wise analyses from Aim 1. This difference is likely due to the lack of nuance and
variability from the categorical variable of the percentage of individuals with
psychological comorbidities utilized in Aim 1. The variable utilized in Aim 2, however,
represents overall self-reported psychological functioning and well-being in the MTBI
group compared to the controls. This continuous variable does not require a diagnosis of
a mental health disorder to be made as the variable from Aim 1 does. This does, however,
highlight the importance of psychological assessment as part of routine clinical care for
MTBI.
Previous studies with homogenous samples have found that various demographic
factors, such as sex (Bazarian et al., 2010), education (Dougan et al., 2014), and race
(Shafi et al., 2007), may modify MTIB recovery. However, supplemental analyses from
the present study found that demographic variables (percentage of females and ethnic
minorities included in the study sample, age, education), injury parameters (percentage of
participants reporting LOC and PTA), and study characteristics (utilization of PVTs) did
not predict overall neurocognitive outcomes post-MTBI. Similar to some published
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studies (Collie et al., 2006; Iverson et al., 2004; Sterr et al., 2006) supplemental analysis
did indicate that the report of PCS in the MTBI group relative to the control group did
predict cognitive functioning. However, much like the other variables, this failed to reach
significance when simultaneously entered with psychological functioning. Perhaps, the
initial PCS finding was driven by the affective symptomology of PCS (e.g., irritability,
fatigue) versus pain (e.g., headache, photophobia), which was better explained by overall
psychological functioning.
Overall, the meta-regression models from Aim 2 suggest the time that has elapsed
after sustaining an MTBI is predictive of neurocognitive dysfunction only in the first 90
days post-injury. However, psychological functioning is the most important predictor of
neurocognitive outcomes post-MTBI. That is, across a heterogenous population of
individuals who sustain MTBI, psychological functioning better predicts neurocognitive
recovery, over and above the latency from the initial injury.
Methodological Considerations
The present study diverged from methodology utilized in prior MTBI metaanalyses in several meaningful ways. First, a random-effects meta-analysis was
conducted instead of fixed-effects analysis, which can result in smaller, more
conservative estimates of effect sizes since two sources of error (within-study and
between-study) are considered. Additionally, outcomes from multiple time points were
not averaged as was done in other studies (e.g., Belanger, Curtiss, et al., 2005; Binder et
al., 1997). Rather, in line with study aims, the time point with the greatest latency since
the initial injury was selected from each study for analysis. This was done to better
understand the factors that moderated cognitive recovery as opposed to documenting the
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more acute effects of MTBI, per se. This decision may have led to systematically smaller
estimates of effect sizes than if we were to have averaged all the time point comparisons.
Notably, due to the large number of studies that met potential inclusionary criteria, a
random sample of articles were reviewed until a specified number (k = 45) of studies per
population were included. Given that a random-effects analysis assumes a random
distribution of effects, and the process of reviewing articles was also randomized, we do
not believe that this process biased the observed effects in any particular direction.
Finally, in an effort to ensure the construct validity of the cognitive outcomes, this study
only included validated neuropsychological assessments and excluded experimental
measures (e.g., fMRI paradigms; Pertab et al., 2009). The ability to be selective with
psychological assessments is a luxury that previous meta-analyses were not afforded
given the recent increase in published MTBI research. It is uncertain if this decision
would lead to a systematic bias in observed effect sizes in either direction. Despite these
potentially meaningful differences, most of the outcomes were consistent with prior
analyses. When there were differences, however, the effect sizes tended to be larger;
though this is most likely due to the increased heterogeneity of study populations relative
to previous analyses.
As outlined above, despite these methodological differences, most of the analyses
from the present study are consistent with the findings from previous meta-analytic
reviews. A notable discrepancy in our findings from prior meta-analytics studies was the
small, but statistically significant effect size that remained in the GMR group after 90
days, which differed from most meta-analytic studies that divided outcomes by a similar
time frame (Belanger, Curtiss, et al., 2005; Pertab et al., 2009; Rohling et al., 2011; c.f.,
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Frencham et al., 2005). This finding may be due to the relatively larger inclusion of
studies in the present analysis (k = 18) compared to previous analyses (mean k = 10.5).
Notably, most of these previous studies investigated a “mixed” population that included
some athletes, likely decreasing the observed effect sizes. The only study with a “true”
GMR sample was Belanger’s (2005a) analysis that included eight studies, which found a
negligible effect size (d = .04) after 90 days. Perhaps, the small, but significant effect size
observed in the present study is a more accurate representation of MTBI recovery for this
group, and this study has the power to detect such finding. Alternatively, this finding may
be due to a cultural shift in our understanding of the deleterious effects of MTBI in the
nearly 10 years since the previous GMR study was published, and individuals may be
more likely to seek medical care when their “bell is rung” rather than “walking it off.”
While it was consistent with our hypotheses, another divergent finding from
previous MTBI research was that age was not a significant predictor of post-injury
cognitive functioning. Dougan and colleagues (2014) found that, in athletes, higher age
resulted in lower neuropsychological effect sizes. Their study, however, had a relatively
restricted age range (15-33 years vs. 4.87-69.1 years) and was limited to athletes in the
acute phases of the injury (1-10 days). The present finding is consistent with a systematic
review, which found no consistent evidence that age was not a reliable predictor of longterm neurocognitive functioning. Notably, there was a relative dearth of pediatric and
older adult studies in the present analysis. This is particularly problematic for
generalizability as epidemiological studies have found a bimodal distribution in TBI
prevalence with children and older adults having the highest rate of injury (Faul et al.,
2010).
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The differences in results from the present study relative to previous metaanalytic reviews may also be due to the uniqueness of the variables of interest. To our
knowledge, this is the first published study that included Veteran samples in a
quantitative review of cognitive functioning after sustaining an MTBI. These analyses
found that studies that included Veteran populations exhibited significantly larger
cognitive sequalae after an MTBI relative to their non-injured counterparts. This is likely
due to the “cumulative model” in which the physical, emotional, cognitive, vocational,
and psychosocial stressors Veterans face when returning from deployment may
exacerbate premorbid risk factors, leading to worse outcomes (Evered, Ruff, Baldo, &
Isomura, 2003; Ruff et al., 1996). Additionally, the methodological decision to exclude
studies with assessments greater than three years post-injury resulted in the exclusion of
many Veteran studies, which preludes a comprehensive understanding of how Veteran
recovery from MTBI. For example, a preliminary unpublished project stemming from the
methodology and article selection of the present study found a much smaller effect size
(Hedges g = .34) across 18 studies when there were no exclusions based on time of
assessment (mean time since injury = 43.59 months; Marston, 2019). Nonetheless, the
current project is the first meta-analytic study that attempts to understand the
neurocognitive trajectory for Veterans and factors that may modify cognitive recovery.
Another novelty is the inclusion of psychological variables in this meta-analytic
study. While many empirical studies (e.g., Combs et al., 2015; Nelson et al., 2012;
Verfaellie et al., 2014) and systematic reviews (e.g., Carroll et al., 2004) have examined
the role of psychological functioning in post-MTBI cognitive recovery, this is the first
meta-analysis, to our knowledge, that attempted to control for the effect of psychological
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functioning on neurocognitive outcomes. Despite this analysis only including 36 studies,
the overwhelming ability of psychological functioning to predict study-level data, speaks
to the importance of emotional well-being for cognitive recovery after an MTBI.
Despite attempts to systematically integrate a broad literature to derive findings
that will generalize across populations, the study is not without limitations. One
limitation of this research is the relatively restricted age ranges of selected samples and
relatively small number of Veteran samples included, potentially reducing
generalizability. On the other hand, this study included an extremely heterogenous study
sample, which has inherent potential for generalizability across many other variables.
Another limitation is the small number of studies used for the analysis of psychological
functioning in Aim 2 (k = 36). Given that most studies included did not directly measure
psychological functioning (>70%) efforts to replace these data (e.g., imputations) were
not conducted. Nonetheless, the ability of this variable to explain nearly all betweenstudy variability speaks to its robustness and predictive ability across samples.
Additionally, a notable criticism of all MTBI meta-analyses is that the methods of
aggregating outcomes across studies may mask the minority of individuals who
experience protracted recovery (the so-called “miserable minority”), giving the false
impression that no one experiences residual cognitive sequalae after three months (Pertab
et al., 2009). On the contrary, our significant cognitive findings after 90 days suggest that
these individuals may not be lost in our analyses. Finally, it is important to note that
meta-regression analyses are inherently observational in nature. The data from the present
study are study-level data, not patient-level data. Thus, caution needs to be taken in over-
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generalizing these findings and assuming that psychological functioning causes
protracted cognitive recovery after MTBI.
Clinical Implications
Recognizing the significance of psychological functioning status-post injury has
great clinical utility and should result in improved care and management of individuals
after an MTBI. Assessment of emotional well-being and psychological functioning
should be part of routine clinical care for management of MTBI across all populations.
Individuals who screen high for psychological distress may benefit from a referral for
brief Cognitive Behavioral Therapy (CBT) or another therapeutic intervention. Brief
CBT has been found to reduce the duration and severity of PCS after MTBI (Miller &
Mittenberg, 1998; Silverberg et al., 2013). For example, a small pilot study found that
individuals who were at high risk for persistent PCS and received brief CBT reported
fewer symptoms and were less likely to be diagnosed with Post-Concussive Syndrome
than patients who received treatment as usual (Silverberg et al., 2013). Additionally, this
study suggests that patients who suffer an MTBI may benefit from psychoeducation
regarding the overall in the non-specific symptomology between MTBI and mental health
disorders (e.g., fatigue, inability to concentrate, irritability).
Patients should be empowered to seek mental health treatment in the acute
recovery process, especially if there are pre-morbid psychological concerns, rather than
waiting three months or more. Neuropsychologists, who are uniquely trained to assess
cognitive, biological, and psychological factors, should be a part of all multi-disciplinary
MTBI teams. The present research also speaks to the growing need for acute MTBI
detection and care for military Veterans. Given the high rate of PTSD symptomology
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(Carlson et al., 2009) and other mental health disorders, our research suggests this
population is particularly vulnerable to poorer neurocognitive functioning after MTBI. In
recent years, emphasis on Veteran care and research has increased. For example, the
Defense and Veterans Brain Injury Center published clinical guidelines for the
management and clinical care of Veterans with MTBI in 2006 (Moy, Martin, Scwhab, &
Malik, 2018). Within 30 days of returning from deployment, Veterans meet with a health
care provider to assess current health functioning and evaluate for deployment-related
occupational and environmental exposure (Brenner, Vanderploeg, & Terrio, 2009). In
2008, head injuries were added to the list of environmental exposures that Veterans were
to be screened. Positive exposure would result in referrals to appropriate services (e.g.,
Poly-Trauma, neuropsychology). Nonetheless, careful and effective screening for mental
health disorders and expansion of therapeutic services may be beneficial for improving
Veteran’s long-term functioning after MTBI.
Summary
In sum, this study is the largest MTBI meta-analysis to date, which utilized
contemporary analytic techniques to assess changes in cognitive functioning status-post
MTBI. A medium-large decrement was observed in overall neurocognitive functioning in
the very acute (< 24 hours) period post-MTBI. Meta-regression showed time to be
significant predictor of cognitive functioning in the first 90 days, predicting a small (d =
.20) effect size after 41 days. After, 90 days, time since injury was no longer a significant
predictor of cognitive functioning. Psychological functioning was found to be the most
robust predictor of overall cognitive functioning after MTBI across heterogenous
samples. Future research should further elucidate and attempt to validate the specific
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psychological constructs that may confound cognitive recovery. Finally, given the high
prevalence of MTBI and the general lack of access to healthcare in the US, especially
with minority groups, CBT or Prolonged Exposure, to treat MTBI via computer or
telemedicine should be developed.
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Appendix A
Flowsheet Outlining Approach to Initial Abstract Review and Article Coding

Available
Information

Humans

Empiricle
Study?

MTBI

•Are the titles and abstracts complete? If not, Code 0 - Insufficient Information
•Is it published in English? If not, code "Not Published in English"

•Does it involve humans?
•No? Code as "Animal Study"

•Is this an empirical study? If not, code as "not an empirical study"
•E.g., poster abstracts, non-systematic reviews, book chapters without data, position statements
•If the article is a systematic review or meta-analysis, code as "Systematic Review/Meta-analysis"

• Is the article about the cognitive/psychological effects of sustaining an MTBI? If not, code as "MTBI not primary focus)
• E.g., Adherence to return-to-play protocols, survey of MTBI knowledge among coaches, computer models of hit-velocity ot sustain an MTBI
• Did an MTBI occur? If not, code "MTBI did not occur"
• E.g., only baseline data; moderate or severe TBI only; healthy controls surveyed for PCS
• Is MTBI poorly defined or lumped together as a "closed head injury" or other antiquated terms that does not delinate injury severity? Code "MTBI not
Defined"
• Use this one sparingly and infrequently as this may be elucidated when coding the full article

•Exclude and code if a study is a "csae study/case series" as sample size is too small and would not be approrpiate
control group
•If no control group is mentioned (self or other) and the results only describe comparison of the MTBI group to
Study Design itself or morderate or severe TBI code "Lack of Appropriate Control Group"

Assessment

•Were neuropsychological or cognitive (not a neurologic exam or GCS) assessed (experimental and tasks used
during imaging studies are included)? If not, code "No Neuropsychological Assessments Used"
•If all the above criteria is met, however, the study is a behavioral or pharmacological intervention study, code as
"Intervention study"
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Appendix B
MTBI Data Entry Code Sheet
Identifying Information:
Author – Type in the last name of the first author.
Year – The year the article was first published. If article was published in print first, then
online (i.e., re-print), enter the year that the article first appeared in print.
***Note: If there are multiple articles included in the study with the same first author
published the same year, differentiate the articles by placing letters (in alphabetical order)
after the year. Example: Belanger 2005a; Belanger 2005b; Belanger 2005c
Country – The country that data collection took place. If it took place in multiple
countries, enter the country that the first author is from.
Study Characteristics:
Appropriate Method of Defining MTBI – Enter either “Yes” or “No.” MTBIs must be
generally aligned with the ACRM or WHO guidelines (i.e., acute mental alterations, GCS
13-15, LOC < 30 minutes, PTA < 24 hours). If unsure, ask David Marra
Method Used – Briefly described how MTBI was defined (e.g., “Blunt head trauma;
LOC < 30 minutes)
Imaging Study – Enter either “Yes” or “No.” If the study included neuroimaging (i.e.,
MRI, CT, MEG) or EEG, enter “Yes.” If no neuroimaging is reported as part of the
study, enter “No.”
PVTs Used to Exclude Invalid Performance – Enter either “Yes” or “No.” If the study
specifically states that subjects were removed due to invalid performance, then enter
“Yes.” If not, enter “No.”
Types of PVTs Used: If “Yes” to “PVTs Used to Exclude Invalid Performance,” then
enter the types of PVTs used. Enter either, “Stand-alone” (e.g., VSVT, TOMM, WMT),
“Embedded” (e.g., Reliable Digit Span, CVLT-FC), “Both” (e.g., used both embedded
and stand-alone), or “Unspecified” if the article did not directly state how they assessed
effort.
Control Group: Enter the appropriate control group used in the study. Either “NonInjured Controls,” “Pre-Injury Baseline,” “Non-Injured Controls & Pre-Injury Baseline,”
or “Orthopedic Injury.”
MTBI Sample Demographics:
Population - Enter either: Athlete, Veteran, General Medical Referral, Litigant, or
Mixed: General Medical/Litigant.
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Mean Age – Enter the mean age of the MTBI sample
Age Category – Based on the mean age of the MTBI sample, select: Children (Ages 013), High School/College (Ages 14-22), Adults (Ages 23-64), Older Adults (Ages 65+)
Mean Education – Enter mean educational attainment of the MTBI sample
Based on the MTBI sample, enter the percentage of females, percentage of Caucasians,
percentage of Blacks, percentage of Latinos, and percentage of individuals of other races
Mechanism of Injury – based on the MTBI sample, calculate the percentage of
individuals who suffered an MTBI due to play an Impact Sport (i.e., Football, Lacrosse,
Boxing, Hockey, Rugby, MMA), Other Sport (e.g., Soccer, Basketball, Baseball,
Wrestling), Motor Vehicle Accident (MVA), Falls, Blast Injury, Veteran Blunt Trauma
(Veterans who suffered an MTBI due to blunt force trauma – but not due to a blast),
Civilian Assault (i.e., victims of a crime/mugging), Other Mechanisms (i.e., any other
mechanism of injury not covered above)
Complicated TBI – the percentage of individuals who suffered a complicated MTBI
(i.e., skull fracture, subdural hematoma) as confirmed by neuroimaging
Psychological Comorbidity & Personality Constructs:
Composition of Psych Comorbidity – the study specifically states that subjects were
excluded due to a psychological comorbidity (e.g., depression, PTSD, anxiety), then
select “0%.” If the sample or subsample of individuals have a diagnosed psychological
comorbidity, then select “100%.” If the article does not specify, or some individuals (but
not all) have a mental health disorder, then select “Mixed.”
Based on the MTBI sample, enter the percentage of the MTBI sample with a diagnosis
of Depression, Anxiety, PTSD, and Substance Use Disorder (SUD).
Time and Time Points:
Mean Time Since Injury - Enter the mean time since MTBI occurred (in months) from
the MTBI sample. If multiple measurements occurred during the course of the study,
average the time points together. Example: if measurements an evaluation took place at 1
month and 6 months, then enter “3.5 months.”
***Note: if the evaluation took place days (rather than months) after the initial
evaluation, then convert the number of days into months by dividing by 30. If the
evaluation took place hours after the evaluation, first convert the number of hours postTBI into days, then into months by dividing by 30.
Example:
7 days = .233 months (7/30)
6 hours = .0083 Months (6 / 24 / 30)
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Time Category: Based on the Mean Time Since Injury, enter the following: < 24 hours,
< 7days, < 3 months, > 3 months
Number Post-Injury Time Points: Enter the number of evaluations that took place over
the course of the study.
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